NIH Clinical Research Studies Listed By Protocol Number

 12-NR-0054:

Integrative Genomic Analysis In Phantom Limb Pain

 12-N-0104:

Validating a New Writer's Cramp Scale

 12-N-0095:

Clinical and Molecular Manifestations of Neuromuscular and Neurogenetic Disorders of Childhood

 12-N-0065:

Experienced Breacher Study: Evaluation of the Effects from Chronic Exposure to Low-Level Blast

 12-N-0060:

Structural and Functional Brain Imaging Markers of Upper Motor Neuron Function

 12-N-0033:

A Phase Two Clinical Trial of Buspirone Therapy in Localization-Related Epilepsy

 12-N-0031:

Imaging Biomarkers in Parkinson Disease

 12-N-0030:

Fatigue and Amotivation Following Mild Traumatic Brain Injury and their Influence on Service Member Community Reintegration

 12-N-0024:

Dose Escalation Study of Oral Octanoic Acid in Patients with Essential Tremor

 12-N-0007:

Prospective Evaluation of the Effect of Corticotropin-Releasing Hormone Stimulation on 18F-Fludeoxyglucose High-Resolution Positron-Emission Tomography in Cushing's Disease

 12-M-0099:

Pharmacogenetics and Neuroimaging in Major Depressive Disorder (PAN-D)

 12-M-0063:

PET Imaging of Translocator Protein in Subjects with Traumatic Brain Injury

 12-M-0059:

Inflammation and Function of P-gp in HIV Infection of Brain

 12-I-0121:

Screening of Volunteers for Clinical Trials of Investigational Vaccines and Antiviral Products

 12-I-0115:

A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antiviral Activity of GS-9620 in Treatment Naive Subjects with Chronic Hepatitis C Virus I

 12-I-0072:

A Phase 2b Randomized, Double-Blind, Double-Dummy Trial of 100 or 200 mg Once-Daily Doses of Cenicriviroc (CVC, TBR-652) or Once-Daily EFV, Each with Open-Label FTC/TDF, in HIV-1-Infected, Antiretroviral Treatment-Naive, Adult Patients with Only CCR5-Tro

 12-I-0041:

VRC 311: A Phase 1 Open Label, Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Virus-Like Particle (VLP) Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

 12-I-0026:

Assessment of Glucocorticoid Responsiveness and Mechanisms of Resistance in Hypereosinophilic Syndromes

 12-HG-0053:

International Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of KIACTA in Preventing Renal Function Decline in Patients With AA Amyloidosis

 12-H-0127:

A Phase 1, Placebo-Controlled, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating, Single Oral Doses of Aes-103 in Subjects with Stable Sickle Cell Disease

 12-H-0110:

An Open-label, Non-Randomized, Single-Arm Pilot Study to Evaluate the Effectiveness of Etidronate Treatment for Arterial Calcifications due to Deficiency in CD73 (ACDC)

 12-H-0103:

Characterization of Innate Immune Responses to MF59 Adjuvanted H5N1 Vaccine Compared to Non-adjuvanted H5N1 Vaccine

 12-H-0101:

Measurement of the Reactive Hyperemia Index in Sickle Cell Patients During Pain Crisis and After Recovery

 12-H-0093:

A Pilot Study of Treatment of Adults with Sickle Cell Disease Associated Pulmonary Hypertension Based on Hemodynamic Stratification: Safety and Tolerability Study of Imatinib and Carvedilol

 12-H-0084:

Metabolic Phenotyping of Subjects with Mutations Associated with Hereditary Parkinson's Disease

 12-H-0078:

Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD with Depressed Left Ventricular Function

 12-H-0070:

A Pilot Two-Step Phase II Study of the Oral Gold Compound Auranofin in Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)/Prolymphocytic Lymphoma (PLL)

 12-H-0069:

End-Alveolar Carbon Monoxide as a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease

 12-H-0064:

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

 12-H-0052:

Prospective Randomized Trial on Radiation Dose Estimates of CT Angiography in Patients Applying Iterative Image Reconstruction Techniques

 12-H-0035:

A Phase II Study of PCI-32765 for Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Need Therapy and are Older than 65 or have a 17p Deletion

 12-H-0028:

Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using Ex Vivo CD3, CD19 Depletion and CD34 Selection

 12-H-0025:

Real-time MRI Pericardiocentesis Using Passive Needles

 12-H-0010:

A Phase I Study of Bone Marrow Stromal Cell Infusions to Treat Acute Graft Versus Host Disease, Marrow Failure and Tissue Injury After Allogeneic Stem Cell Transplantation

 12-EI-0119:

Phase II, Randomized, Placebo-Controlled Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy

 12-EI-0085:

Blood and Saliva Sample Collection and Submission to the Age-Related Eye Disease Study 2 (AREDS2) Genetic Repository

 12-EI-0057:

A Phase I Study to Investigate Subconjunctival Sirolimus for the Treatment of Active Autoimmune Non-Necrotizing Anterior Scleritis

 12-EI-0042:

NEI Intramural Biorepository for Retinal Diseases

 12-EI-0013:

Pilot Phase I/II study of the Treatment of classic Centeral Serous Chorioretinopathy with Topical Inerferon Gamma-1b

 12-E-0089:

Bisphenol A (BPA) Pharmacokinetic (PK): Controlled Exposure Study

 12-E-0061:

The Role of the Functionally Relevant Single Nucleotide Polymorphisms CYP2J2 -50G>T (CYP2J2 7) and EPHX2 9846A>G (EPHX2 K55R) in Human Endothelial Function

 12-DK-0097:

Energy Expenditure Responses to Different Temperatures

 12-DK-0071:

Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults with Chronic Hepatitis B

 12-DK-0046:

Treatment of Chronic Delta Hepatitis with Lonafarnib

 12-D-0100:

Oral Microbial and Immunological Characterization of Patients with Immune Dysfunction

 12-CH-0083:

The Effectiveness of Botulinum Toxin on Persistent Pelvic Pain in Women with Endometriosis

 12-CH-0062:

Investigations into ISCU Myopathy

 12-CH-0051:

Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function

 12-CH-0050:

The Role of Gonadotropin Pulsations in the Regulation of Puberty and Fertility

 12-CH-0049:

The Molecular Basis of Inherited Reproductive Disorders

 12-CH-0016:

Bone Marrow Cell Engraftment of the Uterus

 12-CH-0011:

Non-Invasive Study of Brain Connectivity Using Combined EEG and NIRS

 12-CC-0096:

Collection of Granulocytes by Apheresis of Healthy Donors Stimulated with Filgrastim (G-CSF) and Dexamethasone

 12-CC-0082:

Imaging the GABAergic System Using 11C-flumazenil PET to Assess the Role of Mild Traumatic Brain Injury in the Development of Post Traumatic Stress Disorder

 12-CC-0017:

The Influence of Atazanavir-ritonavir and Efavirenz on Atovaquone Pharmacokinetics in HIV-infected Volunteers

 12-CC-0001:

Biochemical and Genetic Mechanisms of Acute Clinical Pain During Bone Marrow Aspiration

 12-C-0116:

A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Aldesleukin for Human Papillomavirus-Associated Cancers

 12-C-0114:

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

 12-C-0113:

A Phase I Study of a Continuous Intravenous Infusion of Recombinant Human Interleukin IL-15 (rhIL-15) in Adults with Metastatic Cancers

 12-C-0112:

Phase I Study of T Cells Expressing an Anti-CD19 Chimeric Receptor in Children and Young Adults with B Cell Malignancies

 12-C-0111:

Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-mesothelin Gene Engineered Lymphocytes

 12-C-0107:

Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: A Clinical and Correlative Study

 12-C-0106:

Novel Imaging Modalities to Characterize Angiogenesis in the Bone Marrow Microenvironment in Multiple Myeloma (MM) and its Precursor Disease

 12-C-0098:

A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults with Relapsed / Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma

 12-C-0091:

A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children with Refractory or Recurrent Solid Tumors and Lymphomas

 12-C-0087:

A Phase II, Multi-Center, Open-Label Study Evaluating GRN1005 Alone or in Combination with Trastuzumab in Breast Cancer Subjects with Brain Metastases

 12-C-0081:

Phase I/II Study of Cediranib and Olaparib in Combination for Treatment of Recurrent Papillary-Serous Ovarian, Fallopian Tube, or Peritoneal Cancer or for Treatment of Recurrent Triple-Negative Breast Cancer

 12-C-0080:

NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients with Metastatic Castrate-Resistant ProstateCancer to Bone Treated with either Docetaxel-Based Chemotherapy or Androgen Receptor (AR)-Directed Therapies

 12-C-0079:

A Phase II Study of AMG 386 and Abiraterone in Metastatic Castration Resistant Prostate Cancer

 12-C-0074:

Mobilization and Collection of Autologous Stem Cell for Transplantation (ASCT) for Plasma Cell Myeloma (PCM)

 12-C-0068:

A Randomized Double-Blind Pilot Study of Topical Clobetasol 0.05% Oral Rinse for Oral Chronic Graft-Versus-Host-Disease

 12-C-0066:

Phase I Trial of Oral 5-Fluoro-2-Deoxycytidine with Oral Tetrahydrouridine in Patients with Advanced Solid Tumors

 12-C-0058:

A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type-1 and Chemotherapy-Refractory Radiographic Progressive Low-Grade Gliomas

 12-C-0056:

An Open Label Phase I Study to Evaluate the Safety and Tolerability of GI-6301 Vaccine Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express Brachyury Protein in Adults with Solid Tumors

 12-C-0047:

A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals With or Without HIV

 12-C-0045:

Phase II Study in Patients with Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of MART-1 Reactive Peripheral Blood Lymphocytes (PBL) With or Without High Dose Aldesleukin

 12-C-0043:

Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients with Relapsed and Refractory Disease

 12-C-0027:

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

 12-C-0014:

Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine

 12-C-0009:

Phase Ib Study of the Combination of Pazopanib, an Oral VEGFR Inhibitor, and ARQ 197 (Tivantinib), an Oral MET Inhibitor, in Patients with Refractory Advanced Solid Tumors

 12-C-0008:

An Open Label Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Maximum Tolerated Dose of the Antimesothelin Antibody Drug Conjugate BAY 94-9343 in Subjects with Advanced Solid Tumors

 12-C-0005:

Phase I Trial of AZD7451, A Topomysin-Receptor Kinase (TRK) Inhibitor, For Adults with Recurrent Gliomas

 12-C-0004:

A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma

 12-C-0003:

Phase I/II Trial of Yttrium-90-labeled Daclizumab (anti-CD25) Radioimmunotherapy with High-dose BEAM Chemotherapy and Autologous Hematopoietic Stem Cell Rescue in Recurrent and Refractory Hodgkin's Lymphoma

 12-AA-0032:

Measuring Effects of Acute Ethanol on Human Brain Metabolites using Magnetic Resonance Spectroscopy

 11-NR-0213:

Biomarkers-driven Development of Experimental Therapeutics for Traumatic Brain Injury

 11-NR-0189:

Biochemical and Genetic Mechanisms for Etiology of Sickle Cell Pain

 11-NR-0084:

Evaluation and Diagnosis of Potential Research Subjects with Traumatic Brain Injury (TBI)

 11-NR-0065:

Characterization of the Molecular-Genetic Mechanisms Associated with Chemotherapy-Induced Peripheral Neuropathy Progression

 11-NR-0014:

Investigating Molecular-Genetic Correlates of Fatigue Experienced by Cancer Patients Receiving Treatment

 11-N-0261:

Evaluation of Skeletal Muscle, Cardiac, and Diaphragm Imaging Biomarkers for GSK2402968 Effects in Ambulatory Boys with Duchenne Muscular Dystrophy

 11-N-0211:

Deep Brain Stimulation Surgery for Movement Disorders

 11-N-0210:

NIB Repository Protocol

 11-N-0204:

Prospective, Randomized Controlled Trial of Surgical Resection Prior to Bevacizumab Therapy for Recurrent Glioblastoma Multiforme

 11-N-0182:

The Role of the Inferior Frontal Gyrus in Long-Term Auditory Memory - a rTMS Study

 11-N-0171:

Effect of Functional Exercise in Patients with Spinal and Bulbar Muscular Atrophy

 11-N-0157:

Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Obsessive-Compulsive and Movement Disorders

 11-N-0090:

Structural and Functional Neuroimaging Studies of Combat Veterans

 11-N-0085:

Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension

 11-N-0055:

The Effect of Transcranial Magnetic Stimulation on Learning with Reward in Healthy Humans

 11-N-0051:

Surgery as a Treatment for Medically Intractable Epilepsy

 11-N-0039:

A Phase II Clinical Trial of PRX-00023 Therapy in Localization-Related Epilepsy

 11-M-0251:

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty

 11-M-0229:

PET Imaging of Brain mGlu1 Receptors Using [11]LY2428703

 11-M-0202:

PET Imaging of CB1 Receptors Using [11C]SD5024

 11-M-0195:

The Serotonin-1A Receptor Radioligand (18F)FCWAY as a Potential Substrate for Efflux Transport at the Blood-Brain Barrier

 11-M-0144:

Markers of Autism Spectrum Disorders in At-Risk Toddlers: A Pilot Study

 11-M-0118:

Neuroimmune Activation in Austism: Imaging Translocator Protein Using Positron Emission Tomography (PET)

 11-M-0104:

The Role of Oxytocin and Arginine Vasopressin in Human Placebo Analgesia

 11-M-0058:

A Placebo-Controlled Trial of Intravenous Immunoglobulin (IVIG) for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections)

 11-M-0045:

Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites and Neurotransmitters in Human Brain

 11-I-0259:

Phase 1 Study of Safety and Immunogenicity of Ad4-H5-VTN in Ad4 Seronegative Volunteers

 11-I-0257:

VRC 312: A Phase 1, Open-Label, Dose-Escalation Clinical Trial with Experimental Challenge to Evaluate Intravenous Administration of the PfSPZ Vaccine in Malaria-Naive Adults

 11-I-0253:

An Open Label, On-Treatment Trial to Assess the Effect of HIV-1 Coinfection on Therapeutic Responses using Boceprevir, Peg-Interferon-alfa-2b and Ribavirin in HCV Genotype 1, IFN Treatment-Naive Subjects with or without HIV-1

 11-I-0205:

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of DAS181 in Patients with Parainfluenza Infection

 11-I-0197:

VRC 016 A Phase 1b Open-Label, Randomized Clinical Trial to Evaluate Early Innate and Adaptive Immune Responses to the Investigational HIV-1 Vaccines: VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP in Ad5 Seronegative Healthy Adults

 11-I-0187:

The Natural History, Immunologic Correlates and Genetic Defects in Patients with Mucocutaneous and Invasive Fungal Infections

 11-I-0183:

Screening of Volunteers for Influenza Human Challenge Studies

 11-I-0164:

VRC 500:Screening of Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes

 11-I-0128:

A Multicenter, Open-Label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses

 11-I-0109:

Viral Infections in Healthy and Immunocompromised Hosts

 11-I-0057:

Effect of Interferon Alpha 2b Intensification on HIV-1 Residual Viremia in Individuals Suppressed on Antiretroviral Therapy

 11-I-0046:

Cross-Sectional Characterization of Idiopathic Bronchiectasis

 11-I-0031:

A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults

 11-HG-0238:

Weight Management Interactions in a Virtual Clinical Environment

 11-HG-0218:

A Natural History Study of Patients with Hereditary Inclusion Body Myopathy (HIBM)

 11-HG-0217:

The NIH UNI Study: Urea Cycle Disorders, Nutrition and Immunity

 11-HG-0207:

Clinical and Basic Investigations Into Erdheim-Chester Disease

 11-HG-0110:

Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations

 11-HG-0093:

Personalized Genomic Research: Congenital Malformations

 11-H-0268:

The Safety and the Tolerability of Ultra Low Dose Interleukin-2 in Healthy Volunteers

 11-H-0252:

Exploratory Studies of Psychophysical Pain Phenotyping and Genetic Variability in Sickle Cell Disease

 11-H-0224:

Contrast-Enhanced Ultrasound Imaging of Carotid Plaque Neovascularization

 11-H-0209:

Male Hormones for Telomere Related Diseases

 11-H-0184:

An Extended Phase II Study of Decitabine in Subjects with High Risk Sickle Cell Disease

 11-H-0134:

A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Moderate Aplastic Anemia Patients

 11-H-0121:

Pilot Trial of the Safety and Efficacy of Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients with Hemolytic Disorders

 11-H-0092:

Effects of Systemically Administered Hydrocortisone on the Human Immunome in Healthy Volunteers

 11-H-0091:

Real-Time MRI Right Heart Catheterization Using Passive Catheters

 11-H-0068:

Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans

 11-H-0064:

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

 11-EI-0264:

A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein Occlusions

 11-EI-0263:

A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branched Retinal Vein Occlusions

 11-EI-0249:

Pilot Study of the Evaluation of Intravitreal Sirolimus in the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration

 11-EI-0245:

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Best Disease, Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) Patients

 11-EI-0244:

A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2)

 11-EI-0173:

The Natural History of Ocular Graft-Versus Host Disease

 11-EI-0147:

Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration

 11-EI-0124:

Home Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the Foresee Home Device

 11-EI-0107:

Treatment of Non-infectious Panuveitis, Intermediate and Posterior Uveitis Associated Macular Edema with Intravitreal Methotrexate

 11-EI-0066:

A Phase I Unmasked Study to Investigate the Safety and Tolerability of Subconjunctival Injections of Palomid 529 in Patients with Neovascular Age-Related Macular Degeneration

 11-E-0072:

Environmental Risk Factors for the Anti-Synthetase Syndrome

 11-E-0006:

The Role of TGF-Beta in Asthmatic Epithelial Cell Susceptibility to RSV Infection

 11-DK-0256:

Pharmacokinetic and Pharmacodynamic Studies of Liothyronine. A Study on the Metabolic Effects of Thyroid Hormone

 11-DK-0168:

Magnetic Resonance Arterial Wall and Angiography Imaging for Non-Invasive Assessment of Arterial Distensibility, Endothelial Dysfunction and Atherosclerotic Disease Using High Field (3T) MRI: A Technical Development Study

 11-DK-0151:

Withdrawal of Therapy After Long-Term Oral Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B

 11-DK-0114:

A Pilot Trial of YF476, A Gastrin Antagonist, in Patients with Type II Gastric Carcinoids Associated with Zollinger-Ellison Syndrome

 11-DK-0108:

Observational Study of Persons with Hepatitis B Virus Infection in North America (Cohort Study)

 11-DK-0023:

The Nephrotic Syndrome Study Network (NEPTUNE)

 11-D-0172:

The Pathogenesis and Natural History of Sjogren's Syndrome

 11-D-0094:

A Randomized Within-Subject, Double-Blind, Placebo-Controlled Study of Dexamethasone Irrigation of the Parotid Glands in Primary Sjogren's Syndrome Subjects

 11-CH-0239:

Mood and Insulin Resistance in Adolescents At-Risk for Diabetes

 11-CH-0208:

Effects of the Glucocorticoid Antagonist, Mifepristone, on Glucose Intolerance in Obese and Overweight Individuals

 11-CH-0194:

Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation

 11-CH-0179:

Next Generation Sequencing to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols

 11-CH-0119:

Adrenal Hyperplasia Among Young Women with Polycystic Ovarian Syndrome

 11-CH-0078:

Evaluation of Cortisol Resistance in Young Endurance-Trained and Elderly Men

 11-CH-0004:

Free Fatty Acids, Body Weight, and Growth Hormone Secretion in Children

 11-CC-0265:

A Pilot Study to Examine Physiological and Clinical markers of Chronic Stress in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

 11-CC-0246:

Characteristics and Mechanism of Childhood-Onset Hemidystonia

 11-CC-0203:

Effect of Time Varying Walking Velocity in Body-Weight Supported Treadmill Training

 11-CC-0201:

The Effect of Music Listening on the Amount of Opioids Used in Surgical Intensive Care Patients

 11-CC-0152:

The Natural History of Liver Disease in a Cohort of Participants with Hepatitis B and/or Hepatitis C with or without HIV Infection

 11-CC-0137:

Testing Subjects with Traumatic Brain Injury using Haptic Technology

 11-CC-0131:

Phase Ib Study of the Safety and Pharmacokinetics of Chemoembolization with Irinotecan-Eluting Beads for the Treatment of Hepatic Metastases

 11-CC-0120:

Stereophotogrammetry of the Torso in Normal Individuals and Patients with Scoliosis, Chest Wall Deformations, or Obesity

 11-CC-0088:

Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients with Traumatic Brain Injury

 11-CC-0083:

Beyond Intuition: Quantifying and Understanding the Signs and Symptoms of Fever

 11-CC-0082:

Prospective Randomized Trial Comparing Navigation with Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures

 11-CC-0063:

Evaluating Supportive Care for Children with Cancer: A Multi-Institutional Survey Study of Pediatric Oncology Patients and Parents

 11-CC-0037:

Mobility Training to Improve Motor Behavior in Toddlers with or at Risk for Cerebral Palsy - A Pilot Study

 11-CC-0032:

Cancer, Vulnerability, and Financial Quality of Life: A Mixed Methods Study

 11-C-0267:

A Phase 2, Randomized, Multicenter, Open-Label Study of the Efficacy and Immune Response of the Sequential Adminstration of GVAX Pancreas Vaccine (with Cyclophosphamide) Alone or Followed by CRS-207 in Adults with Metastatic Pancreatic Adenocarcinoma

 11-C-0266:

A Phase I/II Study of the Safety and Feasibility of Administering T Cells Expressing Anti-EGFRvIII Chimeric Antigen Receptor to Patients with Malignant Gliomas Expressing EGFRvIII

 11-C-0262:

A Randomized, Double-Blind, Phase 3 Efficacy Trial of PROSTVAC-V/F plus or minus GM-CSF in Men with Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Prostate Cancer

 11-C-0260:

A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma

 11-C-0255:

Clinical, Epidemiologic, and Genetic Studies of Li-Fraumeni Syndrome

 11-C-0250:

A Phase 1, Open-Label, Dose Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Combined Oral C-Met/ALK Inhibitor (PF-02341066) and Pan-Her Inhibitor (PF-0299804) in Patients with Advanced Non-Small Cell Lung Cancer

 11-C-0248:

Phase I Trial of ECI301 in Combination with Radiation in Patients with Advanced or Metastatic Cancer

 11-C-0240:

A Phase 1 Dose Escalation Study of Hepatic Intra-Arterial Administration of TKM 080301 (Lipid Nanoparticles Containing siRNA Against the PLK1 Gene Product) in Patients with Colorectal, Pancreas, Gastric, Breast, Ovarian and Esophageal Cancers with Hepati

 11-C-0233:

Pilot Study of Tocilizumab in Patients with Symptomatic Kaposi Sarcoma Herpesvirus (KSHV) - Associated Multicentric Castleman Disease

 11-C-0232:

A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination with mTOR Inhibitor RAD001 (Everolimus) in Patients with Relapsed Multiple Myeloma or Lymphoma

 11-C-0227:

Multi-Center Phase 1B/II Trial of Gemcitabine, Cisplatin, Plus Lenalidomide as First Line Therapy for Patients with Metastatic Urothelial Carcinoma

 11-C-0226:

Targeted Theraphy of Bronchiolitis Obliterans Syndrome (BOS)

 11-C-0225:

First In-Human Phase I Trial of NHS-IL12 in Subjects with Metastatic Solid Tumors

 11-C-0221:

Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Clinical and Correlative Phase II Study

 11-C-0220:

Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS) Incorporating Pilot Evaluation of KSHV Targeted Therapies

 11-C-0212:

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin over Expressing Cancers

 11-C-0200:

A Phase II Trial In Which Patients With Metastatic Alveolar Soft Part Sarcoma Are Randomized to Either Sunitinib or Cediranib Monotherapy, with Cross-Over at Disease Progression

 11-C-0193:

A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination with a Platinum Containing Doublet in Chemotherapy-Naive Subjects with Stage IV Adenocarcinoma of the Lung

 11-C-0192:

A Phase I Trial of Peptide-Based Glioma Vaccine IMA950 in Patients with Glioblastoma (GBM)

 11-C-0191:

Phase 1 and Pharmacokinetic Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma

 11-C-0181:

A Phase II Study of TRC105 in Patients with Hepatocellular Carcinoma (HCC) Who Have Progressed on Sorafenib

 11-C-0170:

A Phase I/II Study of IL-15 Administration Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen and Autologous Lymphocyte Transfer in Metastatic Melanoma

 11-C-0163:

Phase II Study of Lymphocytes Generated with Engineered Cells for Costimulation Enhancement in Patients with Metastatic Melanoma Following Lymphodepletion

 11-C-0162:

A Multicenter, Open-Label, Phase 2, Safety and Efficacy Study of the Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI-32765, in Subjects with Relapsed or Refractory De Novo Diffuse Large B-Cell Lymphoma

 11-C-0161:

A Phase 1 Study of the Mitogen Activated Protein Kinase Kinase (MEK) 1 Inhibitor AZD6244 Hydrogen Sulfate (Selumetinib Sulfate) in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

 11-C-0160:

A Pilot Study of Pentostatin Plus Cyclophosphamide Immune Depletion to Decrease Immunogenicity of SS1P in Patients with Mesothelioma

 11-C-0159:

A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma

 11-C-0158:

MR Image Guided Focal Theraphy in Prostate Cancer

 11-C-0150:

Phase I Study of the Hsp90 Inhibitor, PU-H71, in Patients with Refractory Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma

 11-C-0149:

Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm

 11-C-0148:

Autologous Tumor Cell Vaccs and ISCOMATRIX(TM) Adjuvant with Metronomic Oral Cyclophosphamide and Celecoxib in Pts Undergoing Resection of Sarcomas, Melanomas, Germ Cell Tumors, or Epithelial Malignancies Metastatic to Lungs, Pleura or Mediastinum

 11-C-0146:

A Multicenter Phase II Study of Enhancement of Immune Reconstitution and Vaccine Responses with Administration of Glyco-Recombinant Human IL-7 in Older Subjects Following Chemotherapy

 11-C-0142:

A Phase 1 Study of JAK Inhibition (INCB018424) in Children with Relapsed or Refractory Solid Tumors, Leukemias, and Myeloproliferative Neoplasms

 11-C-0141:

A Phase 1 Study of MK-2206, an AKT Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors or Leukemia

 11-C-0140:

A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients with Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors

 11-C-0136:

Multi-Institutional Prospective Pilot Study of Lupron to Enhance Lymphocyte Immune Reconstitution Following Allogeneic Bone Marrow Transplantation in Post-Pubertal Children and Adults with Molecular Imaging Evaluation

 11-C-0132:

Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer

 11-C-0129:

A Pilot Trial Assessing the Feasibility of Delivering Topical MTS-01 to Reduce Dermatitis in Patients Receiving Intensity Modulated Radiation with Concurrent 5-Fluorouracil and Mitomycin-C for Stage I-III Carcinoma of the Anal Canal

 11-C-0125:

Relapsed Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation: Screening, Disease Characterization and Natural History

 11-C-0123:

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction with 12Gy Total Body Irradiation (TBI)

 11-C-0122:

Phase I Trial of AZD8055, An Oral MTOR Kinase Inhibitor, for Adults with Recurrent Gliomas

 11-C-0117:

Pilot Study of the Combination of MK-2206, an AKT Inhibitor, and AZD6244, a MEK Inhibitor, in Patients with Advanced Colorectal Carcinoma

 11-C-0113:

A Pilot Study of Genetically Engineered NY-ESO-1 Specific (c259) T cells in HLA-A2+ Patients with Synovial Sarcoma

 11-C-0112:

Acquisition of Blood and Tumor Tissue Samples from Patients with Gastrointestinal Cancer

 11-C-0111:

Adjuvant Allogeneic Tumor Cell Vaccine with Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Sarcomas, Melanomas, Germ Cell Tumors, or Epithelial Malignancies Metastatic to Lungs, Pleura, or Mediastinum

 11-C-0102:

A Phase I/II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma (HCC)

 11-C-0099:

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

 11-C-0098:

Evaluation of Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer

 11-C-0096:

Pilot Trial of Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

 11-C-0081:

(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients with Gliomas

 11-C-0080:

Ph II Randomized Trial of the Combination of ABT-888 with Metronomic Oral Cyclophosphamide in Refractory BRCA-Pos Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Neg Breast Cancer, and Low-Grade NHL

 11-C-0077:

Phase II Study of Oral PHA-848 125AC in Patients with Malignant Thymoma Previously Treated with Multiple Lines of Chemotherapy

 11-C-0075:

A Phase 1 Study of AZD6244 in Combination with Cetuximab in Refractory Solid Tumors

 11-C-0073:

A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias

 11-C-0061:

Phase I Trial of Z-Endoxifen in Adults with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or other Hormone Receptor-Positive Solid Tumors

 11-C-0060:

A Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction

 11-C-0053:

A Phase I Study of Temirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Tumors

 11-C-0048:

A Phase II Study of Lapatinib for the Treatment of Stage IV Melanoma Harboring ERBB4 Mutations

 11-C-0047:

A Phase I Trial and Pharmacokinetic Study of the Oral Platinum Analog Satraplatin in Children and Young Adults with Refractory Solid Tumors including Brain Tumors

 11-C-0044:

Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics with Non-Small Lung Cancer

 11-C-0042:

Pilot Study of Weekly EZN-2208 (Pegylated SN-38) in Combination with Bevacizumab in Refractory Solid Tumors

 11-C-0041:

Epigenetically-Modified Autologous Tumor Cell Vaccines with ISCOMATRIX(TM) Adjuvant and Oral Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas

 11-C-0038:

A Phase 2 Study of Vorinostat in Subjects with Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) (IND 71976)

 11-C-0036:

A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes

 11-C-0035:

BRCA1 and BRCA2 Mutations and Triple Negative Disease in Hispanic/Latino Breast Cancer Subjects

 11-C-0034:

Dicer1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

 11-C-0033:

Extended Follow-up of High Ovarian Cancer Risk Cohort from 02-C-0268 (GOG-199)

 11-C-0029:

Phase I Study of the HSP-90 Inhibitor, AT13387, in Adults with Refractory Solid Tumors

 11-C-0027:

A Phase I/II Trial of Crolibulin (EPC2407) plus Cisplatin in Adults with Solid Tumors with a Focus on Anaplastic Thyroid Cancer (ATC)

 11-C-0026:

An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients with Advanced Solid Tumors and Lymphomas

 11-C-0024:

A Phase II Trial of IPH2101 (Anti-KIR) in Smoldering Multiple Myeloma (SMM)

 11-C-0022:

A Pharmacokinetic/Pharmacodynamic Study with a Phase I Run-In with a PARP Inhibitor (Olaparib) in Combination with Carboplatin for Refractory or Recurrent Women's Cancers

 11-C-0016:

Multi-Center Phase I Study of Th1/Tc1 Immunotheraphy Following Autologous Hematopoietic Progenitor Cell Transplantation in High Risk Multiple Myeloma

 11-C-0013:

Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes

 11-C-0011:

Phase I/II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Tumor Infiltrating Lymphocytes Genetically Engineered to Express IL-12

 11-AT-0188:

A Pilot Study to Evaluate the Effect of Acupuncture on Epigenetic Regulation of Inflammatory Mediators in Participants with Chronic Low Back Pain

 11-AR-0241:

A Pilot Study of Anakinra Behcet's Disease (BD)

 11-AR-0223:

Studies on the Natural History and Pathogenesis of Spondyloarthritis

 11-AR-0156:

Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study

 11-AA-0180:

Genetics of the Acute Response to Alcohol in Humans

 11-AA-0028:

Dietary Linoleic Acid Regulation of Omega-3HUFA Metabolism: Satiety and Body Composition Among Overweight Female Subjects

 11-AA-0010:

Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics

 10-N-0212:

Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients with Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)

 10-N-0199:

Ethanol Response in Essential Tremor: Clinical and Neurophysiological Correlates

 10-N-0193:

Using Positron Emission Tomography (PET) to Predict Intracranial Tumor Growth in Neurofibromatosis Type II (NF2) Patients

 10-N-0185:

Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury

 10-N-0143:

A Prospective Natural History Study of Patients with Syringomyelia

 10-N-0125:

Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)

 10-N-0121:

Oxidative Stress in Motor Neuron Disease: COSMOS-PLS Add-On Study

 10-N-0057:

The Influence of Sensory Stimuli on Gait Imagery in Patients with Freezing of Gait

 10-N-0015:

Cerebral Activity Related to Primary Motor Stereotypies in Children: An EEG Study

 10-N-0012:

Screening Protocol for Patients with Stroke

 10-N-0009:

Physiological Investigations of Movement Disorders

 10-N-0003:

Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: A MEG Study

 10-M-0204:

PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [(11)C]NOP-1A

 10-M-0192:

An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States

 10-M-0112:

Defining the Brain Phenotype of Children with Williams Syndrome

 10-M-0068:

Effects of Prosocial Neuropeptides on Human Brain Function in Healthy Volunteers and Individuals with Autism Spectrum Disorders

 10-M-0058:

Imaging Cannabinoid CB1 Receptors in Schizophrenia

 10-M-0049:

Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers

 10-M-0047:

Top-Down Attentional Control of Visual-Processing

 10-M-0027:

Cognitive Neuroscience of Autism Spectrum Disorders

 10-M-0024:

A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for Obsessive-Compulsive Disorder

 10-I-0216:

Studies of Disorders with Increased Susceptibility to Fungal Infections

 10-I-0210:

A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications

 10-I-0206:

Treatment of Mucocutaneous Leishmaniasis-Mucosal and/or Cutaneous Leishmaniasis-with Miltefosine

 10-I-0205:

Assessment of Alterations in Immune Function During Pregnancy and Post Parturition

 10-I-0197:

Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases

 10-I-0196:

Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders

 10-I-0195:

Training Protocol on the Natural History of Tuberculosis

 10-I-0159:

Study to Evaluate the Genetic, Epigenetic, and Proteomic Expression in Latino Participants with and without HIV Coinfection Receiving Treatment for Hepatitis C

 10-I-0148:

Natural History of Atopic Dermatitis and Other Genetic/Congenital Diseases Associated with Allergic Inflammation

 10-I-0139:

Searching for Persistence of Infection in Lyme Disease

 10-I-0123:

Assessment of the Biochemical Response to Interferon-Gamma in Subjects with Specific Gene Mutation in Chronic Granulomatous Disease

 10-I-0109:

VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

 10-I-0101:

A Randomized, Placebo-controlled, Double-Blind Pilot Study of Single-Dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection

 10-I-0100:

A Pilot Study Using Anakinra/Kineret for the Treatment of Patients with Severe Atopic Dermatitis

 10-I-0095:

Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers

 10-I-0080:

Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology

 10-I-0055:

An Open-label, Multicenter Study of Subcutaneous Intermittent Recombinant Interleukin-7 (CYT107) in Chronically HIV-Infected Patients with CD4 T-Lymphocyte Counts Between 101-400 cells/mm(3) and Plasma HIV RNA less than 50 copies/mL After at Least 12 Mon

 10-I-0043:

A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza A Immune Plasma for the Treatment of Influenza A

 10-I-0029:

Non-Invasive Assessment of Atherosclerosis in Patients with CGD and Other Disorders of the Immune System

 10-I-0014:

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients without Known Immunocompromise

 10-HG-0151:

Quality of Life and Neuropsychiatric Sequelae in Patients Treated with Gene Therapy for ADA-SCID and in their Parents

 10-HG-0065:

Whole Genome Medical Sequencing for Gene Discovery

 10-H-0177:

A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia

 10-H-0176:

Cyclophosphamide Plus Cyclosporine in Treatment-Na ve Severe Aplastic Anemia

 10-H-0168:

Submission of Autologous and Related Allogeneic Hematopoietic Stem Cell Transplant Data to the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP)

 10-H-0165:

Effects of Rosuvastatin on the Immune System in Healthy Volunteers with Normal Cholesterol

 10-H-0162:

Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples from Patients and their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies

 10-H-0154:

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused with a Reduced Dose of Non-Mobilized Donor T-Cells

 10-H-0141:

A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

 10-H-0126:

Cardiovascular Disease Discovery Protocol

 10-H-0097:

A Study of the Kinetics of Lymphoid Cells in Patients with Monoclonal B-Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers.

 10-H-0088:

Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol

 10-H-0039:

New Techniques to Evaluate Mitral Regurgitation

 10-H-0034:

Cardiac MRI for Patients Enrolled in INFUSE-AMI

 10-EI-0191:

Peptide B27PD (Optiquel(Registered Trademark)) as Corticosteroid-sparing Therapy for Chronic Non-infectious Uveitis (BOOTS)

 10-EI-0169:

Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients with and without Diabetic Macular Edema

 10-EI-0140:

Genotype-Phenotype Study of Patients with Plaquenil(Registered Trademark)-Induced Retinal Toxicity, with Evaluation of the ABCA4 Gene

 10-EI-0093:

Immunogenetic Mechanisms in Behcet's Disease

 10-EI-0040:

Rituximab for Autoimmune Retinopathy

 10-EI-0016:

Internal Monitoring of Eye Movement in Schizophrenia

 10-E-0134:

Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage

 10-E-0130:

The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease

 10-E-0129:

Study of the Effect of Innate Immunity on the Inflammatory Response to Endotoxin

 10-E-0063:

Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing

 10-DK-0187:

Duration of Long-Term Immunity After Hepatitis B Virus Immunization

 10-DK-0163:

Metabolic Effects of Non-Nutritive Sweeteners

 10-DK-0135:

Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes

 10-DK-0064:

Effects of Caloric Restriction Alone versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients with Diabetes Mellitus

 10-DC-0211:

Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy

 10-D-0180:

A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer

 10-D-0020:

The Molecular Anatomy of Oral Wound Healing

 10-CH-0198:

Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging

 10-CH-0144:

The Natural History of Reproductive and Overall Health in Women with a Pre-Mutation in the FMR1 Gene: Creation of a Patient Registry

 10-CH-0084:

Studies of Autistic Patients: Gene Networks and Clinical Subtypes

 10-CH-0083:

A Phase I Trial of Safety and Immunogenicity of Gardasil(Registered Trademark) Vaccination Post Stem Cell Transplantation in Patients with and without Immunosuppression

 10-CH-0022:

Exome Sequencing in Autistic Spectrum Disorder Patients with Altered Cholesterol Homeostasis

 10-CC-0217:

A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy

 10-CC-0214:

Randomized Trial of Imaging Versus Risk Factor Based Therapy for Plaque Regression

 10-CC-0200:

Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections

 10-CC-0153:

Noninvasive Imaging of Heart Failure

 10-CC-0150:

Effects of Rapid-Resisted Exercise on Ambulatory Adults with Traumatic Brain Injury

 10-CC-0149:

Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection

 10-CC-0118:

Long Term Clinical Correlates of TBI: Imaging, Biomarkers, and Clinical Phenotyping Parameters

 10-CC-0115:

Imaging Techniques in MRI

 10-CC-0073:

Physical, Functional and Neurological Effects of Two Lower Extremity Exercise Programs in Children with Cerebral Palsy

 10-CC-0053:

Collection of Bone Marrow from Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products

 10-C-0220:

Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Children and Adolescents with Refractory Cancer

 10-C-0219:

A Phase I Trial of Lenalidomide and Radiotherapy in Children with Diffuse Intrinsic Pontine Gliomas and High-grade Gliomas

 10-C-0218:

Randomized Phase II Study of AZD6244 MEK-Inhibitor with Erlotinib in KRAS Wild Type and KRAS Mutant Advanced Non-Small Cell Lung Cancer

 10-C-0203:

Phase II Study of Axitinib (AG-013736) with Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer

 10-C-0201:

Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells from Patients with DOCK8 Deficiency, LAD-1, and GATA2 Deficiency

 10-C-0189:

A Phase 1, Dose Escalation Study of MGAH22 (Fc-Optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Refractory HER2 Positive Breast Cancer and Patients with Other HER2 Positive Carcinomas for Whom no Standard Therapy is Available

 10-C-0179:

GE148-002: A Phase 2, Open-label, Single-Center, Study to Assess GE-148 (18F) Injection Positron Emission Tomography(PET) Imaging to Detect Localized Prostate Cancer

 10-C-0178:

A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma

 10-C-0174:

Pilot Study of Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

 10-C-0170:

Lung Cancer Mutation Consortium Protocol

 10-C-0166:

A Phase II Study Using Short-Term Cultured, CD8+-enriched Autologous Tumor-Infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Digestive Tract Cancers

 10-C-0138:

Allogeneic Tumor Cell Vaccine with Metronomic Oral Cyclophosphamide and Celecoxib as Adjuvant Therapy for Lung and Esophageal Cancers, Thymic Neoplasms, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas

 10-C-0132:

A Phase I Study of AZD6244 in Combination with Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum

 10-C-0114:

A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

 10-C-0113:

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults with Advance Solid Tumors

 10-C-0111:

Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) Children's Oncology Group

 10-C-0105:

A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children with Gliomas

 10-C-0102:

Clinical and Genetic Studies in Familial Non-Medullary Thyroid Cancer

 10-C-0096:

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

 10-C-0089:

Phase II Study of Oral PHA-848125AC in Patients with Thymic Carcinoma Previously Treated with Chemotheraphy

 10-C-0086:

Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies

 10-C-0077:

A Phase 1/2 Study of PXD101 (Belinostat) in Combination with Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic Malignancies

 10-C-0071:

Phase 2, Open-Label Arm Study of the Efficacy and Safety of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring a Translocation or Inversion Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus

 10-C-0067:

A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

 10-C-0066:

Collection of Human Samples to Study Hairy Cell and Other Leukemias and to Develop Recombinant Immunotoxins for Cancer Treatment

 10-C-0062:

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

 10-C-0056:

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

 10-C-0054:

Administration of Anti-CD19-Chimeric-Antigen-Receptor-Transduced T-cells from the Original Transplant Donor to Patients with Recurrent or Persistent B-Cell Malignancies After Allogeneic Stem Cell Transplantation

 10-C-0052:

Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, c-MYC Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma

 10-C-0051:

A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin suppressor) in Subjects with Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)

 10-C-0050:

A Randomized Phase II Study of Rituximab with ABVD Versus Standard ABVD for Subjects with Advanced-Stage Classical Hodgkin Lymphoma with Poor Risk Features (IPS score >2)

 10-C-0041:

A Phase II Trial of Valproic Acid in Patients with Advanced Thyroid Cancers of Follicular Origin

 10-C-0025:

Randomized Phase II Trial of Rituximab with Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

 10-C-0021:

A Phase I Study of Intravenous Recombinant Human IL-15(rhIL-15) in Adults with Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer

 10-C-0011:

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

 10-AA-0046:

Effects of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism on Stress-Induced Craving in Alcoholic Women with High Anxiety: an Experimental Medicine Study

 09-NR-0131:

Fatigue in Healthy Individuals

 09-NR-0088:

Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy

 09-NR-0064:

Brain-Gut Interactions in Overweight and Normal Weight Patients with Chronic Abdominal Pain

 09-N-0197:

Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients with Primary Progressive Multiple Sclerosis

 09-N-0182:

GABA/Glutamate Balance in Temporal Lobe Epilepsy with and without Major Depression

 09-N-0118:

Investigation of Neurofeedback with Real-Time fMRI in Healthy Volunteers and Patients with Hyperkinetic Movement Disorders

 09-N-0117:

An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients with Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma

 09-N-0032:

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the CNS

 09-N-0010:

Biomarkers of Risk of Parkinson Disease

 09-M-0240:

An Investigation of the Antidepressant Effects of a Low-Trapping Mixed NR2A/2B Antagonist in Treatment-Resistant Major Depression

 09-M-0198:

Screening and Evaluation of Patients with Signs and Symptoms of Alzheimer's Disease

 09-M-0194:

Characterizing Lone Parenting: A Multi-Institutional Pilot Study of the Perceptions of Support and Perceived Stress of Lone Parents of Children with Cancer

 09-M-0176:

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients with Schizophrenia: Characterization through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

 09-M-0171:

Characterization of Autism Spectrum Disorder in School Aged Children

 09-M-0123:

Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation

 09-M-0042:

Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder

 09-M-0040:

Imaging Cannabinoid CB1 Receptors in Alcohol Dependence

 09-M-0034:

A Controlled Trial of Citalopram Added to Methylphenidate in Youth with Severe Mood Dysregulation

 09-M-0022:

The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study

 09-I-0246:

A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-Borne Encephalitis (TBE) for NIAID Workers Manipulating Tick-Borne Encephalitis Virus (TBEV) in the Laboratory

 09-I-0226:

A Pilot Study for Collection of Anti-Influenza A H1N1 Immune Plasma

 09-I-0200:

A Phase I Study of Mozobil (TM) in the Treatment of Patients with WHIMS

 09-I-0184:

Studies in the Pathogenesis of Systemic Capillary Leak Syndrome

 09-I-0172:

Natural History of Bronchiectasis

 09-I-0170:

Immune Responses to Varicella-Zoster Virus Vaccination and Infection

 09-I-0163:

HVTN 505: Ph 2 RPCT Test-of-Concept Trial to Eval Safety/Effect Post-HIV Acquisition Viremia of Multiclade HIV-1 DNA Plasmid Vaccine F/B Multiclade HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Adenovirus Type 5 Neutralizing AB Negative,

 09-I-0157:

Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection

 09-I-0133:

Establishing Fibroblast-derived Cell Lines from Skin Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders

 09-I-0129:

A Randomized Double-Blinded, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

 09-I-0126:

Pathogenesis of Physical Induced Urticarial Syndromes

 09-I-0108:

Strategic Timing of AntiRetroviral Treatment (START)

 09-I-0102:

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

 09-I-0086:

Screening Protocol for Genetic Diseases of Allergic Inflammation and Mast Cell Homeostasis and Activation

 09-I-0069:

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

 09-I-0049:

Normal Blood, Bone Marrow and Buccal Mucosa Protocol

 09-I-0030:

Clinical and Immunologic Monitoring of Patients with Known or Suspected HIV Infection

 09-I-0013:

Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults

 09-HG-0128:

Leukodystrophies of Unknown Cause

 09-HG-0035:

Clinical, Cellular, and Molecular Investigations into Oculocutaneous Albinism

 09-H-0244:

A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

 09-H-0229:

Collection of Blood, Bone Marrow, and Buccal Mucosa Samples from Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Laboratory Research Studies

 09-H-0225:

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia

 09-H-0201:

Screening Protocol for Subjects being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols

 09-H-0199:

A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R agonist), Eltrombopag, in Patients with Low to Int-2 Risk Myelodysplastic Syndrome (MDS)

 09-H-0183:

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or with a Suboptimal Response to Rabbit ATG/CsA Treatment

 09-H-0166:

Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation

 09-H-0154:

A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients with Immunosuppressive-Therapy Refractory Thrombocytopenia

 09-H-0094:

A Pilot Study of the Safety and Efficacy of Escalating Doses of ON 01910.Na in Patients with Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies

 09-H-0087:

Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

 09-H-0050:

Surgical Interventions for Moderate Ischemic Mitral Regurgitation

 09-DK-0223:

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

 09-DK-0140:

Natural History of Autoimmune Diabetes and Its Complications

 09-DK-0081:

Selective Reduction of Dietary Carbohydrate Versus Fat: Effects on Metabolism, Endocrine Physiology, Brain Activity and Reward Circuitry

 09-DA-0188:

Cocaine Dependence, Metabotropic Glutamate Receptor Subtype 5 (mGluR5) Density, Genetics and Craving

 09-D-0039:

A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated with Advanced Cancer

 09-CH-0203:

Cholesterol in Autism Spectrum Disorder (ASD): Characterization and Treatment

 09-CH-0180:

Non-Invasive Non-Ionizing Polarized Imaging System to Assess Structure of Cervix

 09-CH-0085:

Global Study of Women's Health

 09-CH-0059:

Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency

 09-CC-0227:

Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness

 09-C-0242:

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

 09-C-0235:

A Phase 2, Open Label Trial of Dacomitinib (PF-00299804) in Selected Patients with Advanced Adenocarcinoma of the Lung

 09-C-0224:

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

 09-C-0222:

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination with Carboplatin versus Carboplatin Alone Followed by Vandetanib Alone in Adults with Recurrent High-Grade Gliomas

 09-C-0210:

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

 09-C-0195:

A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

 09-C-0192:

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

 09-C-0189:

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

 09-C-0173:

A Phase I Study of Belinostat in Combination with Cisplatin and Etoposide in Adults with Advanced Cancers

 09-C-0161:

Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch Studies

 09-C-0130:

Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab Followed by Bevacizumab Monotherapy in Adults with Advanced Kaposi's Sarcoma

 09-C-0120:

An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin

 09-C-0111:

A Phase 1, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612, NSC 281612) in Advanced Malignancies

 09-C-0104:

A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Cross-Over, Phase II.5 Study of Saracatinib (AZD0530), a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung

 09-C-0103:

Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

 09-C-0100:

A Natural History Study of Patients Receiving High Dose Rate Brachytherapy

 09-C-0096:

Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for Patients with GATA2 Mutations

 09-C-0092:

Phase 1/2 Study of Metastatic Renal Cancer using T-Cells Transduced with a T-Cell Receptor which Recognizes TRAIL Bound to the DR4 Receptor

 09-C-0082:

Assessment of the Safety and Feasibility of Administering T cells Expressing an anti-CD19 Chimeric Antigen Receptor to Patients with B-cell Lymphoma or Leukemia

 09-C-0079:

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

 09-C-0072:

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas with Botulinum Toxin

 09-C-0057:

A Phase II Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma

 09-C-0053:

Autologous and Related Allogeneic Hematopoietic Stem Cell Transplant Data Submission to the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP)

 09-C-0037:

A Phase II Clinical Trial of Ixabepilone (Ixempra [R], BMS-247550, NSC 710428), an Epothilone B Analog, in Cervical Cancer

 09-C-0025:

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

 09-C-0019:

A Phase I Study of Dasatinib in Combination with Bevacizumab in Advanced Solid Tumors

 09-C-0005:

Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease

 09-AA-0136:

The Effect of NK1R Antagonism on Alcohol Craving and PTSD Symptoms in Alcohol Dependent Patients with PTSD

 08-NR-0190:

Effects of Chronic Musculoskeletal Pain and Opioidergic versus Placebo Interventions on Neuroendocrine Function in Men

 08-NR-0132:

Evaluation and Diagnosis of Potential Research Subjects with Pain and Fatigue Syndromes

 08-N-0215:

Understanding the Anatomy and Physiology of the Sensory Experience and its Role in Generating Tics in Tourette Syndrome

 08-N-0198:

Warfighter Head Injury Study - a Comprehensive, Multidisciplinary Research Evaluation

 08-N-0181:

Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias

 08-N-0161:

Noninvasive Language Mapping in Patients with Localization-Related Epilepsy

 08-N-0153:

The Role of Autoimmunity in Neurologic Complications of Celiac Disease

 08-N-0044:

A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)

 08-N-0027:

HHV6B in Epilepsy Imaging and CSF Studies

 08-M-0211:

Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)

 08-M-0158:

PET Imaging of Peripheral Benzodiazepine Receptors Using [11C](R)-PK 11195 and [11C]PBR28

 08-M-0150:

An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate with Treatment Response to Citalopram in Patients with Major Depressive Disorder

 08-M-0066:

PET Evaluation of Brain Peripheral Benzodiazepine Receptors using [11C]PBR28 in Neurological Disorders

 08-M-0062:

Brain and Whole Body Imaging of P-Glycoprotein Function Using [11C]dLop

 08-M-0052:

fMRI Investigation of Cortical Reorganization and Phantom Limb Pain Following Amputation

 08-M-0048:

PET Test/Retest Brain Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

 08-I-0221:

Analysis of HIV-1 Replication During Antiretroviral Therapy

 08-I-0184:

Studies in the Pathogenesis of Idiopathic Anaphylaxis

 08-HG-0224:

Clinical and Genetic Studies of VACTERL Association

 08-HG-0059:

Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients

 08-H-0186:

Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity with Bortezomib

 08-H-0185:

Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers

 08-H-0156:

Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies

 08-H-0108:

Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

 08-H-0105:

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

 08-H-0081:

Identification of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients

 08-H-0046:

Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated with Severe Neutropenia Refractory to Immunosuppressive Therapy

 08-H-0016:

Effect of Fasting on the Size of Lymphangioleiomyomas in Patients with Lymphangioleiomyomatosis

 08-EI-0169:

Evaluation and Treatment Protocol for Potential Research Participants with Ocular Diseases

 08-EI-0103:

High Speed Indocyanine Green Angiography Findings in Induction/PRN Regimen of Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration

 08-EI-0102:

Screening Study for the Evaluation and Diagnosis of Potential Research Participants

 08-EI-0099:

Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases

 08-EI-0043:

Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up

 08-EI-0031:

Visual Motor Coordination

 08-DK-0182:

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

 08-DK-0173:

A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy

 08-DK-0165:

Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

 08-DK-0149:

High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed after Standard Therapy

 08-DK-0138:

A New Method for Determining Gastric Acid Output Using a Wireless Capsule

 08-DK-0106:

Hepatitis C Eradication and Progression of Atherosclerosis

 08-DK-0098:

Natural History of Familial Carcinoid Tumor

 08-DK-0004:

High Throughput Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease

 08-CH-0213:

WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation with Genotype

 08-CH-0203:

Comparing Pump vs. Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism

 08-CH-0170:

Establishment of a Fibroid Tissue Bank

 08-CH-0139:

Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity

 08-CH-0085:

Eating Behavior in Adolescents

 08-CH-0022:

Treatment of Menorrhagia in Women with Thrombocytopenia: Comparison of Platelet Transfusion Alone to Platelet Transfusion with Continuous Oral Contraceptive Pills

 08-CH-0001:

Calibration of Non-Invasive Non-Ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers

 08-CC-0205:

Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities

 08-CC-0133:

The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Pulmonary Hypertension: Initial Studies for Establishing Guidelines

 08-CC-0024:

Immunologic and Virologic Response in HIV Infected HLA-B*57 Progressors after Infusion of Lymphocytes from HIV Infected HLA-B*57 "Elite" Long-Term Non-Progressors

 08-C-0214:

A Pilot Study to Evaluate Neuropsychological Outcome Measures and their Relationship with Prognosis in Patients Receiving Radiation Therapy for Brain Metastases

 08-C-0200:

A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma

 08-C-0168:

A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas

 08-C-0151:

A Pilot Study of Sirolimus (Rapamycin, Rapammune[Registered Trademark]) in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN

 08-C-0130:

A Phase II Trial of Peginterferon Alpha-2b (Pegintron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas

 08-C-0123:

A Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (ALL) or Non-Hodgkin's Lymphoma (NHL)

 08-C-0121:

Phase II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes

 08-C-0097:

Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults

 08-C-0092:

A Phase I Study with an Expansion Cohort of the PARP Inhibitor AZD2281 Combined with Carboplatin in BRCA1/2 Familial Breast and Ovarian Cancer and Sporadic Triple Negative Breast and Ovarian Cancer

 08-C-0088:

Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells

 08-C-0083:

Registration Ph III Study of Lucanix (Trademark) in Adv NSC Lung Cancer: An Intl Mltctr RDBPC Study of Lucanix(Trademark) Maint Ther for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Reg of Front-Line, Platinum-B

 08-C-0079:

Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1

 08-C-0078:

A Phase II Trial of Pemetrexed (Alimta [Registered Trademark]) Combined with Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects with Relapsed or Refractory NSCLC

 08-C-0051:

A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies

 08-C-0026:

A Phase 1, Single Center, Dose-Escalation Study of SS1(dsFv)PE38 Administered Concurrently with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Epithelial Pleural Mesothelioma

 08-C-0020:

A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors

 08-C-0015:

A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas

 08-C-0007:

A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer

 08-AA-0178:

Computer-Assisted Self-Administration of Ethanol (CASE) in Humans

 08-AA-0137:

A Randomized, Double-blind, Placebo Controlled Trial (RCT) of Varenicline to Reduce Alcohol Consumption in Heavy Drinkers

 07-N-0190:

Neurobiological Studies of Psychogenic Movement Disorders and Non-Epileptic Seizures

 07-N-0165:

Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients with Dystonia and Healthy Controls

 07-N-0137:

Expanding the Phenotype of the LRRK-2 Mutation in Individuals with History of Parkinson's Disease and their Relatives: a Prospective Study

 07-N-0122:

Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

 07-N-0103:

Imaging Serotoninergic Neurotransmission in Epilepsy

 07-N-0092:

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients with Multiple Sclerosis (MS)

 07-N-0072:

Neural Substrates of Lasting Motor Skill Learning by Spacing Effect

 07-N-0063:

Detecting a Reward Signal in the Motor Cortex

 07-M-0208:

PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [C-11]PBR28

 07-M-0129:

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients with (MCMD)

 07-M-0082:

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203 and [11C]SP203

 07-M-0035:

PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28

 07-M-0021:

Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders

 07-I-0229:

Influenza in the Non-immunocompromised and Immunocompromised Host

 07-I-0183:

The Collection of Research Samples and/or Data for Repository from Related or Unrelated Hematopoietic Stem Cell Transplantation Recipients for the National Marrow Donor Program(Registered Trademark)

 07-I-0142:

Research Respiratory Tract Procedures

 07-I-0075:

Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies or Patients with Autoinflammatory/Immunodysregulatory Conditions: Busulfan-Based Conditioning with Campath- 1H or h-ATG, Radiation, and Sirolimus

 07-I-0033:

Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility

 07-I-0017:

Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease

 07-HG-0132:

Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

 07-HG-0076:

A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)

 07-HG-0002:

ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

 07-H-0157:

Suburban/NHLBI Cardiovascular Disease Screening Protocol

 07-H-0113:

Collection of Blood, Bone Marrow, and Buccal Mucosa Samples from Healthy Volunteers

 07-H-0030:

Metabolic Regulation by Tumor Suppressor p53 in Li-Fraumeni Syndrome

 07-H-0005:

Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease

 07-EI-0145:

Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure

 07-E-0023:

Innate Immunity Signal Transduction in Human Leukocytes

 07-DK-0219:

A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism

 07-DK-0207:

Tenofovir Disoproxil Fumarate Alone Versus its Combination with Emtricitabine for Treatment of Chronic Hepatitis B

 07-DK-0202:

Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans

 07-DK-0163:

The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women

 07-DK-0115:

Natural History of Type 2 Diabetes Mellitus in Children and Young Adults

 07-DK-0077:

Study of the Phenotype of Overweight and Obese Adults

 07-D-0016:

Effects of PTH Replacement on Bone in Hypoparathyroidism

 07-CH-0192:

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoitic Stem Cell Transplant Recipients

 07-C-0195:

Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders

 07-C-0189:

Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents with Hereditary Medullary Thyroid Carcinoma

 07-C-0133:

Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma

 07-C-0130:

A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)

 07-C-0111:

A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies

 07-C-0110:

Analysis of Stored Data Collected from Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols

 07-C-0107:

A Randomized Phase II Trial Combining Vaccine Therapy with PROSTVAC/TRICOM and Flutamide vs. Flutamide Alone in Men with Androgen Insensitive, Non-Metastatic (D0.5) Prostate Cancer

 07-C-0106:

A Randomized Phase 2.5 Study of (153)Sm-EDTMP (Quadramet) with or without a PSA/TRICOM Vaccine in Men with Androgen-Insensitive Metastatic Prostate Cancer

 07-C-0101:

A Phase 0 Trial of (111)Indium CHX-A" DTPA Trastuzumab Imaging in Cancer

 07-C-0100:

Collection of Blood from Patients with Prostate Cancer

 07-C-0087:

A Natural History Study of HIV Acquired in Infancy or Childhood

 07-C-0086:

Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

 07-C-0058:

A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer

 07-C-0053:

A Phase I Trial of Enzastaurin (LY317615) in Combination with Carboplatin in Adults with Recurrent Gliomas

 06-NR-0229:

Neurotropin Treatment of Fibromyalgia

 06-N-0224:

Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases

 06-N-0161:

Long-Term Motor Learning in Focal Hand Dystonia

 06-N-0138:

Long-Term Improvement in Training Effects by Transcranial DC Stimulation

 06-N-0085:

Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence versus Radiation Necrosis

 06-N-0047:

Reference Values for Plasma Catechols

 06-N-0012:

Moving a Paralyzed Hand through a Brain-Computer Interface Controlled by the Affected Hemisphere After Stroke or Traumatic Brain Injury

 06-M-0234:

The Antidepressant Efficacy of the Anticholinergic Scopolamine

 06-M-0215:

Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients

 06-M-0214:

PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome

 06-M-0102:

Clinical and Immunological Investigations of Subtypes of Autism

 06-M-0065:

Screening Protocol for Studies of the Pediatrics and Developmental Neuroscience Branch

 06-I-0217:

Genetic Disorders of Mucociliary Clearance

 06-I-0207:

Investigation of Southern Tick-Associated Rash Illness (STARI)

 06-I-0160:

Tumor Necrosis Factor Alpha Inhibitor (lnfliximab, Adalimumab) Treatment for Crohn's-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences

 06-I-0153:

A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy

 06-I-0086:

A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients with CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy

 06-I-0049:

Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

 06-I-0015:

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

 06-HG-0055:

Functional Imaging in Subjects with Glucocerebrosidase Mutations

 06-H-0248:

Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back

 06-H-0222:

Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

 06-H-0190:

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)

 06-H-0156:

A Pilot Study of the Safety and Activity of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

 06-H-0072:

Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial

 06-EI-0236:

National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases

 06-EI-0230:

Family Studies of Uveal Coloboma

 06-EI-0068:

The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

 06-EI-0059:

Clinical and Molecular Studies in Families with Glaucoma and Related Diseases

 06-EI-0058:

Clinical and Molecular Studies in Families with Myopia and Related Diseases

 06-DK-0183:

Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss

 06-DK-0142:

Peripheral Blood Collection of Adult Stem Cells

 06-DK-0133:

Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study

 06-DK-0079:

The Role of the Orexin System in Body Weight Regulation: Patients with Narcolepsy

 06-DK-0020:

Kidney Disease Biomarkers

 06-CH-0223:

Biobehavioral Study of Recently Adopted Children

 06-CH-0186:

Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C

 06-CH-0011:

Natural History Study of Patients with Excess Androgen

 06-CH-0010:

Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging

 06-C-0233:

A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias

 06-C-0227:

Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies

 06-C-0219:

An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients with Central Nervous System Tumors

 06-C-0213:

Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI)

 06-C-0164:

A Phase II Study of BAY 43-9006 (Sorafenib) in Combination with Cetuximab (Erbitux(Trademark)) in EGFR Expressing Metastatic Colorectal Cancer (CRC)

 06-C-0150:

A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia

 06-C-0115:

Studies on the Mechanism of Action of High-Dose IL-2 in Metastatic Melanoma and Renal Cell Cancer

 06-C-0112:

A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas: Multi-Institutional Trial

 06-C-0051:

AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate with Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy

 06-C-0043:

Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors

 06-C-0014:

Prospective Evaluation of Epigenetic Alterations in Patients with Thoracic Malignancies

 05-N-0228:

The Role of Cortical Coherence in Focal Hand Dystonia

 05-N-0223:

Clinical Neurophysiology: Training and Normative Values

 05-M-0198:

Effect of D-Cycloserine on Treatment of Social Phobia

 05-M-0144:

MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain

 05-M-0105:

Investigating the Neuro-Cognitive Underpinnings of the Emotional Dysfunction Linked to Childhood Behavioral Disturbance

 05-M-0059:

5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement

 05-M-0035:

The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders

 05-I-0219:

Microarray Analysis of Erythema Migrans Lesions

 05-I-0213:

Screening and Baseline Assessment of Patients with Abnormalities of Immune Function

 05-HG-0152:

Variation in Gene Expression in Neurofibromatosis Type 1

 05-HG-0131:

Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)

 05-H-0242:

A Pilot Study of Alemtuzumab (Campath) in Patients with Relapsed or Refractory Severe Aplastic Anemia

 05-H-0206:

A Pilot Study of Alemtuzumab (Campath[R]) in Patients with Myelodysplastic Syndrome (MDS)

 05-H-0130:

Long-Term Evaluation and Follow Up Care of Patients Treated with Allogeneic Stem Cell Transplants

 05-EI-0143:

Molecular Genetics of Retinal Degenerations

 05-EI-0096:

Natural History and Genetic Studies of Usher Syndrome

 05-DK-0119:

Peripheral Thyroid Hormone Conversion and Glucose and Energy Metabolism

 05-DK-0085:

Clinical and Laboratory Investigation of Humans with Informative Iron or Erythroid Phenotypes

 05-DK-0015:

Retinoids for Podocyte Disease

 05-CH-0013:

Adrenal Function in Critical Illness

 05-CC-0091:

Electromagnetic Tracking of Devices During Interventional Procedures: A Pilot Study

 05-C-0252:

Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas

 05-C-0170:

Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib (EPOCH-R-B) Induction Followed by Bortezomib Maintenance Versus Observation in Untreated Mantle Cell Lymphoma with Microarray Profiling and Proteomics

 05-C-0137:

A Phase II Trial of Tamoxifen and Bortezomib in Patients with Recurrent High-Grade Gliomas

 05-C-0044:

Immunologic Studies of Tumors of the Pancreas

 05-C-0010:

Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum

 05-AA-0121:

Assessment and Treatment of People with Alcohol Drinking Problems

 04-N-0071:

Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15R-Beta Subunit (CD122) that Blocks IL-15 Action

 04-M-0222:

Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist

 04-M-0139:

The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women with Menstrual-Related Mood Disorders and Controls

 04-I-0286:

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

 04-I-0266:

Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research

 04-I-0086:

Evaluation of Clinical, Virologic and Immunologic Factors that Contribute to the Pathogenesis of Chronic Hepatitis C and its Complications

 04-HG-0211:

Procurement and Analysis of Specimens from Individuals with Pulmonary Fibrosis

 04-HG-0127:

Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders

 04-HG-0123:

Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics

 04-HG-0093:

Clinical and Genetic Studies on Holoprosencephaly

 04-H-0202:

Human Diseases with Mutation of Non-Muscle Myosin Heavy Chain Genes

 04-H-0179:

Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined with AMD3100 in Healthy Volunteers

 04-H-0161:

Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders

 04-H-0078:

Peripheral Blood Hematopoietic Progenitor Cell Mobilization with AMD 3100 in Healthy Volunteers Previously Mobilized with G-CSF

 04-H-0012:

Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members

 04-EI-0008:

Clinical and Molecular Studies in Families with Corneal Dystrophy or Other Inherited Corneal Diseases

 04-E-0053:

Environmental Polymorphism Registry (EPR)

 04-DK-0021:

Urinary Vitamin C Loss in Subjects with and without Diabetes

 04-CH-0250:

Event Related Potentials in Infants and Adults

 04-CH-0077:

Screening and Diagnosis of Patients with Connective Tissue Disorders

 04-CH-0056:

The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women with Endometriosis

 04-CC-0119:

Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates

 04-C-0281:

Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease

 04-C-0275:

Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity

 04-C-0274:

Follow-Up of Study Subjects Previously Enrolled in Immunotherapy Studies Utilizing Gene Transfer

 04-C-0200:

Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence

 04-C-0177:

A Pilot Study of Tc-94m Sestamibi PET MDR Imaging

 04-C-0165:

Medical Oncology Care in the NCI, Center for Cancer Research

 04-C-0155:

Barrett's Esophagus Early Detection Study

 04-C-0102:

Hematologic Malignancy Biology Study

 04-C-0055:

Allogeneic HSCT without Preparative Chemotherapy or with Low-Intensity Preparative Chemotherapy using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome

 04-AR-0205:

Progression of Spinal Fusion in Ankylosing Spondylitis

 04-AA-0060:

The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration

 03-N-0164:

Evaluation and Treatment of Neurosurgical Disorders

 03-N-0004:

Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure

 03-M-0292:

Psychobiological Mechanisms of Resilience to Trauma

 03-M-0211:

Family Study of Affective and Anxiety Spectrum Disorders

 03-M-0186:

The Psychobiology of Temperament: An fMRI Study

 03-M-0185:

Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning

 03-M-0175:

The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women with Perimenopausal Depression

 03-M-0161:

The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness

 03-M-0143:

Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

 03-M-0138:

A Screening Protocol to Evaluate Women with Postpartum-Related Mood and Behavioral Disorders

 03-M-0108:

Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

 03-M-0093:

Predictability and Aversive Expectancies in Anxiety and Depressive Disorders

 03-M-0092:

An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression

 03-M-0035:

Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-up for Childhood Onset Psychotic Disorders

 03-I-0263:

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

 03-I-0090:

Immune Responses to Vaccinia Virus Vaccination

 03-I-0041:

Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis

 03-HG-0313:

Genetic Analysis of Gray Platelet Syndrome

 03-HG-0264:

Clinical and Molecular Investigations Into Ciliopathies

 03-H-0280:

Disease Pathogenesis and Natural History of Lipid Disorders

 03-H-0250:

Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging

 03-H-0170:

Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease, Thalassemia, and Diamond Blackfan Anemia

 03-H-0168:

Natural History and Molecular Characterization of Benign Ethnic Neutropenia in Individuals of African Descent

 03-H-0105:

The Determination of Genetic Basis Of Immunodeficiency

 03-H-0015:

Collection of Blood from Volunteers and Patients for Studies of Endothelial Function and Systemic Inflammation

 03-EI-0155:

Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)

 03-EI-0123:

Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts

 03-EI-0122:

Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases

 03-EI-0033:

X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies

 03-E-0099:

Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders

 03-DK-0257:

Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance

 03-DK-0256:

Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics

 03-DK-0098:

Study of Thyrotropin Releasing Hormone in Patients with Thyroid or Pituitary Abnormalities

 03-CH-0069:

Early Learning and Development Project

 03-CC-0128:

Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis from Radiologic Images

 03-CC-0060:

Virtual Functional Anatomy (VFA)

 03-C-0278:

A Comparative Study of Pediatric CNS Tumor Activity as Assessed by [18]F-FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging ([1]H-MRSI)

 03-C-0277:

Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols

 03-C-0241:

The Natural History of Childhood Malignancies Treated with Radiation Therapy

 03-C-0145:

Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau

 03-C-0066:

Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer

 03-AR-0298:

A Long-Term Outcome Study with the IL-1 Receptor Antagonist anakinra/Kineret(Registered Trademark) in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of this Disease

 03-AR-0173:

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and other Undifferentiated Autoinflammatory Diseases)

 03-AR-0133:

Clinically Important Changes in Rheumatoid Arthritis

 03-AR-0131:

Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

 02-NR-0169:

Complex Regional Pain Syndrome Proteomics Study

 02-N-0132:

In Vivo Mapping Of Structural and Biochemical Abnormalities In Patients With Primary Focal Dystonia

 02-N-0128:

Evaluation of Tourette's Syndrome with Multimetabolite H-Magnetic Resonance Spectroscopy at 3T

 02-N-0014:

Research Study of Specimens Obtained During Epilepsy Surgery

 02-M-0321:

fMRI Investigation of Explicit Cue and Contextual Fear

 02-M-0263:

Psychopharmacology of Fear-Potentiated Startle in Humans

 02-M-0239:

Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

 02-M-0120:

The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

 02-M-0021:

Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth

 02-I-0308:

Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-Associated Lymphoma

 02-I-0286:

A Pilot Study of the Safety and Efficacy of Imatinib Mesylate in Reducing Eosinophilia in Patients with the Myeloproliferative Variant Hypereosinophilic Syndrome (HES) or Non-Myeloproliferative HES Refractory to Standard Therapy

 02-I-0277:

Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells

 02-I-0232:

HIV Expression in Patients with Viral Loads Suppressed on HAART

 02-I-0202:

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients

 02-I-0147:

Genetic Studies of Chronic Active Epstein-Barr Virus Infection

 02-I-0127:

Screening Subjects for HIV Vaccine Research Studies

 02-I-0110:

Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients

 02-I-0086:

Evaluation of Viral Factors and Immune Parameters to Study HIV-Specific Immunity

 02-I-0055:

Evaluation, Treatment and Follow up of Patients with Lyme Disease

 02-HG-0107:

Investigation of Neurodegeneration in the Glycosphingolipid Storage Disorders

 02-H-0250:

A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H

 02-H-0160:

Peripheral Blood Stem Cell Collection from Adult Volunteers

 02-H-0050:

Technical Development of Cardiovascular Magnetic Resonance Imaging

 02-DK-0022:

Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy

 02-CH-0311:

Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders

 02-CH-0023:

Studies of Pediatric Patients with Metabolic or Other Genetic Disorders

 02-CC-0266:

Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy

 02-CC-0247:

Values at the Bedside: A Survey of European Physicians Regarding Ethical Dilemmas in Clinical Practice

 02-CC-0245:

The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time

 02-CC-0045:

A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between NIH/RMD and NNMC/BCC

 02-C-0313:

Cancer Risk in Xeroderma Pigmentosum Heterozygotes

 02-C-0212:

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

 02-C-0211:

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

 02-C-0210:

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

 02-C-0186:

Eligibility Screening of Patients with CNS Tumors for NCI Clinical Research Protocols

 02-C-0179:

Collection of Blood and Urine from Patients with Cancer

 02-C-0178:

Multidisciplinary Etiologic Study of Familial Testicular Cancer

 02-C-0159:

The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer

 02-C-0144:

Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository from Breast Tissue from Women at High Risk of Breast Cancer

 02-C-0140:

A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative

 02-C-0077:

Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile

 02-C-0064:

Collection of Peripheral Blood and/or Urine From Patients Undergoing Radiation Therapy

 02-C-0052:

Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study

 02-AR-0131:

Collection Of Blood Components Using Apheresis from Patients with Rheumatic Diseases and Healthy Volunteers

 01-N-0206:

Phenotype/Genotype Correlations in Movement Disorders

 01-N-0145:

Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

 01-N-0139:

Evaluation and Treatment of Patients with Epilepsy

 01-N-0007:

Evaluation, Pathogenesis, and Treatment of Patients with or at Risk for Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)

 01-M-0254:

The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers

 01-M-0232:

Positron Emission Tomography (PET) Scanning in Dopamine Disorders: Parkinson's Disease and Schizophrenia

 01-M-0192:

Fluoxetine's Effects on Attention and Emotional Memory in Anxious and Depressed Youth and Adults

 01-M-0185:

Effects of Arousal and Stress on Classical Conditioning

 01-I-0238:

Diagnosis and Treatment of Leishmanial Infections

 01-I-0226:

Evaluation of Immune Response to Vaccines in Primary Immune Disorders

 01-I-0202:

Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections

 01-I-0161:

Identification of Novel Viruses

 01-I-0153:

The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency

 01-HG-0189:

Treatment of SCID due to ADA Deficiency with Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced with a Human ADA Gene

 01-HG-0109:

Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)

 01-H-0198:

Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes

 01-H-0122:

Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy

 01-H-0088:

Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

 01-DK-0062:

Genetic Analysis of Familial Keloids

 01-DK-0053:

Permeability Factor in Focal Segmental Glomerulosclerosis

 01-DC-0230:

Studies of Deficits in the Sense of Taste

 01-DC-0229:

Genetic Analysis of Hereditary Disorders of Hearing and Balance

 01-DC-0228:

Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts

 01-DC-0099:

Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols

 01-D-0184:

Evaluation and Treatment of Bone and Mineral Disorders

 01-CC-0231:

A Prospective Study of Transfusion-Transmitted Infections

 01-CC-0045:

Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

 01-C-0158:

Protocol to Assess Vascularity in Kaposi's Sarcoma Lesions Utilizing Non-Invasive Imaging Techniques

 01-C-0157:

Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols

 01-C-0129:

Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols

 01-C-0070:

Evaluation of the Natural History of Patients with Tumors of the Central Nervous System

 01-C-0038:

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer

 01-C-0030:

Short-Course EPOCH-Rituximab for Untreated CD-20+ HIV-Associated Lymphomas

 01-AR-0227:

Studies of the Natural History of Rheumatic Disease in Minority Communities

 00-NR-0200:

Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain

 00-N-0158:

Trial of Intracerebral Infusion in Patients with Medically Intractable Epilepsy

 00-N-0089:

Genetic Analysis of the Chiari I Malformation

 00-N-0082:

Characterization of Brain Morphology and Activity Using Functional and Anatomical MRI Contrast

 00-N-0043:

Clinical and Molecular Manifestations of Inherited Neurological Disorders

 00-M-0198:

The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder

 00-M-0103:

The Treatment of Menstrually-Related Mood Disorders with Continuous Gonadal Steroid Replacement

 00-M-0085:

Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 3.0 Tesla MRI and Magnetoencephalography

 00-I-0159:

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome

 00-I-0099:

Langherhans' Cell Function and Inflammatory Responses in Skin of Normal Volunteers and Patients with Helminth Infections Using the Suction Blister Technique

 00-HG-0209:

Molecular and Clinical Studies of Primary Immunodeficiency Diseases

 00-HG-0153:

Investigations into Chediak-Higashi Syndrome and Related Disorders

 00-HG-0141:

Clinical, Biochemical, and Molecular Investigations into Alkaptonuria

 00-HG-0058:

Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

 00-H-0051:

Cutaneous Tumorigenesis in Patients with Tuberous Sclerosis

 00-DK-0221:

Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus

 00-DK-0107:

Search for Novel Methods to Detect Acute Renal Failure

 00-DC-0073:

Identification of Hereditary Auditory Temporal Processing Deficits

 00-CH-0219:

Turner Syndrome: Genotype and Phenotype

 00-CH-0180:

Endocrine Studies in Health and Disease

 00-CH-0160:

Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue

 00-CH-0127:

Evaluation of Patients with Endocrine-Related Conditions

 00-CH-0093:

Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma

 00-CH-0035:

The Development of Categorization

 00-CC-0165:

Filgrastim-Mobilized Peripheral Blood Stem Cells for Primary Allogeneic Transplantation Using Unrelated Donors Participating in the National Marrow Donor Program (NMDP)

 00-C-0181:

Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

 00-C-0078:

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with Cancer or Normal Volunteers

 00-C-0074:

Evaluation of Late Effects and Natural History of Disease in Patients Treated with Radiotherapy

 00-AR-0222:

Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions

 99-M-0172:

Integrating EEG/MEG and fMRI: Activity Correlation between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers

 99-I-0084:

To Develop a New Technique to Predict the Occurrence of Pneumocystis Pneumonia, Track its Epidemiology, Diagnose Acute Disease, and Predict and Monitor the Response to Various Therapeutic Agents

 99-H-0076:

Fiberoptic Bronchoscopy in Patients with Asthma

 99-H-0050:

Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases

 99-H-0037:

Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease

 99-DK-0002:

Diabetes and Heart Disease Risk in Blacks

 99-CH-0103:

Evaluation of Women with Endocrine and Reproductive-Related Conditions

 99-CH-0055:

New Imaging Modalities in the Evaluation of Patients with Ectopic Cushing's Syndrome

 99-CC-0168:

Collection and Distribution of Blood Components from Healthy Donors for In Vitro Research Use

 99-CC-0163:

Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 Tesla

 99-C-0128:

Evaluation for NCI Surgery Branch Clinical Research Protocols

 99-C-0099:

Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

 99-AR-0004:

Molecular Basis of Primary Immunodeficiencies

 98-N-0047:

Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

 98-I-0070:

Magnetic Resonance Imaging to Study Avascular Necrosis in HIV-Infected Subjects

 98-I-0027:

The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor and Plerixafor

 98-HG-0249:

Genetic Analysis of Brain Disorders

 98-H-0062:

Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa

 98-D-0145:

Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

 98-CH-0081:

Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome

 98-CC-0090:

Evaluation of Hematologic Patients - Training Protocol

 98-CC-0019:

Normal Volunteer Scanning on MR

 98-C-0037:

Treatment of Children with Cancer

 98-AA-0056:

Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics

 98-AA-0009:

Screening Evaluation for NIAAA Protocols

 97-I-0191:

Studies of Lymphocyte Kinetics Using Stable Isotopes

 97-I-0096:

Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

 97-HG-0192:

Genetic Studies in the Amish and Mennonites

 97-H-0061:

Evaluation and Treatment of Pulmonary Patients not Participating in Research (Training Protocol)

 97-H-0041:

Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols

 97-H-0022:

Bronchoscopy in Patients with Pulmonary Diseases and Research Volunteers

 97-DC-0057:

Genetic Studies of Stuttering

 97-CH-0076:

A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalmic Disorders

 97-CH-0064:

Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta

 97-C-0147:

Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease

 97-C-0143:

Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection

 97-C-0110:

Phase I/II Study of Tac-Expressing Malignancies Other than Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA

 96-I-0129:

Evaluation and Long Term Follow-up of Patients with Allergic and Inflammatory Disorders

 96-I-0052:

A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients with Suspected Chronic Lyme Infection and Selected Control Populations

 96-H-0100:

Role of Genetic Factors in the Pathogenesis of Lung Disease

 96-H-0049:

Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections from Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation

 96-C-0102:

Evaluation and Treatment of Subjects with Dermatologic Diseases

 96-C-0097:

The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases

 96-C-0071:

Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols

 95-M-0150:

A Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings

 95-M-0097:

An Endocrine Model for Postpartum Mood Disorders

 95-I-0066:

Genetic Analysis of Immune Disorders

 95-I-0027:

Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid

 95-HG-0193:

Clinical and Basic Investigations into Hermansky-Pudlak Syndrome

 95-H-0186:

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

 95-H-0047:

Diagnosis and Treatment of Patients with Heart and Vascular Disease (Training Protocol)

 95-CH-0110:

Endometrial Mediators of Gonadal Steroid Action

 95-CH-0059:

Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions

 94-I-0079:

Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans

 94-I-0073:

Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells

 94-HG-0193:

Genetic and Clinical Studies of Congenital Anomaly Syndromes

 94-HG-0132:

The Phenotype and Etiology of Proteus Syndrome and Related Overgrowth Disorders

 94-HG-0105:

Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders

 94-H-0010:

Evaluation, Treatment and Training Protocol for Patients with Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies

 94-E-0165:

Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies

 94-DK-0133:

Genetic Markers for Focal Segmental Glomerulosclerosis

 94-DK-0127:

Pathogenesis of Glomerulosclerosis

 94-D-0018:

Salivary Evaluation in Healthy Volunteers

 94-C-0074:

Treatment and Natural History Study of Lymphomatoid Granulomatosis

 94-AR-0066:

Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)

 93-N-0202:

Diagnosis and Natural History Protocol for Patients with Different Neurological Conditions

 93-M-0170:

Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory

 93-I-0119:

Detection and Characterization of Host Defense Defects

 93-I-0106:

Cryptococcosis in Previously Normal Adults

 93-I-0086:

Evaluation and Long Term Follow Up of Patients with Acute or Chronic Inflammatory Disorders

 93-I-0063:

Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells

 93-I-0057:

Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

 93-DK-0127:

Family Studies in Metabolic Diseases and Mineral Metabolism

 93-C-0133:

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Adults and Children with Previously Untreated Patients with Aggressive Non-Hodgkin's Lymphoma

 92-M-0174:

The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism with and without Estrogen and Progesterone Replacement

 92-I-0125:

A Study of Viral Burden in Peripheral Blood Versus Lymphoid and Bone Marrow Tissue in HIV-Infected Individuals

 92-EI-0113:

Immunopathology and Molecular Pathology of Ocular Diseases in Humans

 92-DK-0156:

Studies of Immunologically-Mediated Kidney Diseases

 92-DK-0033:

Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects

 92-DC-0178:

Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients with Neurologically-Based Language Impairments

 92-CH-0034:

Studies of Growth Deficiency and Growth Hormone Treatment in Children with Osteogenesis Imperfecta Types III and IV

 92-CH-0011:

Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34

 92-C-0094:

Continuing Treatment for Children and Adults in the Center for Cancer Research

 91-I-0140:

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers

 91-DK-0214:

Evaluation of Patients with Liver Disease

 91-DK-0085:

Studies of Hyperparathyroidism and Related Disorders

 91-DK-0066:

Fasting Hypoglycemia: Diagnosis and Treatment

 91-CH-0127:

Ovarian Follicle Function in Patients with Premature Ovarian Failure

 91-CC-0117:

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population

 91-AR-0196:

Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases

 90-M-0142:

Brain Procurement for the Neuropathology Section, CBDB

 90-M-0088:

The Treatment of Menstrually-Related Mood Disorders with the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)

 90-M-0014:

Studies of Frontal Lobe Function During Cognitive Stimulation as Measured with Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients with Neuropsychiatric Disorders

 90-I-0120:

Comparison of Inflammatory Responses in Normal Volunteers and Patients with Abnormal Phagocyte Function Using the Suction Blister Technique

 90-CC-0168:

A Rigid Body Database on Human Movement

 89-N-0045:

Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)

 89-M-0160:

Inpatient Evaluation of Neuropsychiatric Patients

 89-M-0006:

Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls

 89-I-0158:

Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes

 89-DK-0173:

Studies of States with Resistance to Vitamin D and Parathyroid Hormone

 89-DK-0152:

Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity

 89-C-0086:

Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders

 88-M-0131:

The Evaluation of Women with Perimenopause-Related Mood and Behavioral Disorders

 88-I-0083:

Host Response to Infection and Treatment in the Filarial Diseases of Humans

 87-I-0163:

Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

 87-DK-0029:

Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas

 87-CC-0091:

Magnetic Resonance Imaging at 1.5 and 3.0 Tesla

 86-HG-0096:

Studies of Genetic Heterogeneity in Patients with Lysosomal Storage Disorders

 86-EI-0062:

Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis

 85-N-0195:

A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders

 85-I-0127:

Treatment of Cysticercosis including Neurocysticercosis with Praziquantel, Albendazole and other Novel Treatment Modalities

 85-DK-0082:

Acromegaly Treatment and Natural History

 84-M-0050:

Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients

 84-D-0056:

Evaluation of Salivary Gland Dysfunction

 83-C-0022:

Psychological Benefits of a Normalized Camping Experience for Children with Cancer

 82-I-0183:

Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut

 82-H-0032:

Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

 81-M-0126:

The Evaluation of Women with Menstrually Regulated Mood and Behavioral Disorders

 81-I-0164:

Apheresis Procedures to Obtain Plasma or Lymphocytes for In Vitro Studies

 80-M-0083:

Bipolar Genetics: A Collaborative Study

 79-H-0100:

Teaching Protocol for the Evaluation of Plasma Lipoproteins

 78-I-0023:

Diagnosis and Management of Inflammatory and Infectious Diseases

 78-HG-0093:

Natural History Study of the Use of Cysteamine in the Treatment of Cystinosis

 78-C-0039:

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

 77-I-0094:

Study of Patients with Parasitic Infections of the Gastrointestinal Tract

 77-DK-0096:

Studies on Thyroid Nodules and Thyroid Cancer

 77-DK-0002:

Evaluation of Patients with Thyroid Function Disorders

 76-HG-0238:

Diagnosis and Treatment of Patients with Inborn Errors of Metabolism or Other Genetic Disorders

 76-H-0051:

Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients

 76-DK-0006:

Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus

 12-N-0012:

Pilot Study of Bilateral Pedunculo-Pontine Nucleus (PPN) Deep Brain Stimulation for Patients with Parkinson Disease (PD) Who Have Persistent Gait Disturbance, Despite Bilateral Subthalamic Nucleus (STN) Deep Brain Stimulation

 12-CH-0015:

Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Reduce Bleeding in Premenopausal Women with Abnormal Uterine Bleeding: A Pilot Study

 12-CC-0125:

Detection of Respiratory Viruses in Upper and Lower Respiratory Tract Specimens Using a Rapid Multiplex PCR

 12-C-0006:

Phase I/II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Gene Engineered Lymphocytes Cotransduced with Genes Encoding IL-12 and Anti-NY ESO-1 TCR

 11-NR-0030:

Efficacy of Mindful Tai Chi Intervention on Obese and Overweight Adults: A Randomized Controlled Clinical Trial

 11-N-0116:

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People with Multiple Sclerosis

 11-M-0087:

Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression

 11-I-0258:

A Randomized Controlled Study To Assess Safety, Tolerability And Efficacy Of GS-7977 In Combination with Full or Low Dose RBV In HCV Genotype 1, Monoinfected Treatment Naive Participants

 11-I-0007:

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age with X-Linked Severe Combined Immunodeficiency

 11-EI-0012:

Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy

 11-E-0230:

Childhood Asthma Reduction Study

 11-C-0242:

Collection of Blood from Patients with Cancer for Analysis of Genetic Differences in Drug Disposition

 11-C-0216:

Phase I/II Study of MLN4924 Alone Followed by Dose-Adjusted EPOCH-Rituximab + MLN4924 with Gene Expression Profiling and Mutational Analysis in Relapsed/Refractory de novo Diffuse Large B-Cell Lymphoma

 11-C-0130:

A Phase II Study of TRC105 in Adults with Advanced/Mestastic Urothelial Carcinoma

 11-C-0115:

Phase 2 Study of Bevacizumab in Children and Adults with Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma

 11-C-0062:

Phase I/II Study of Metastatic Cancer that Expresses MAGE-A3/12 Using Lymphodepleting Conditioning Followed by Infusion of Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes

 11-C-0021:

A Pilot Study of F-18 Sodium Fluoride PET/CT for Metastatic Burden Qualification in Prostate Cancer

 11-C-0020:

A Pilot Study of Novel Imaging Modalities in Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), and Multiple Myeloma (MM)

 10-NR-0128:

Relationship between Mitochondrial Dysfunction and Fatique in Cancer Patients Following External Beam Radiation Therapy

 10-N-0092:

Genetics of Motor Learning

 10-I-0085:

A Phase 1 Randomized Double-Blind Placebo-Crossover Safety Trial of DAS181 (Fludase(Registered Trademark)) in Adult Subjects with Well-Controlled Asthma or Bronchiectasis

 10-HG-0076:

Mothers' Thoughts About What Their Children Eat

 10-H-0031:

THE IMPROVE TRIAL: Improving Pain Management and Outcomes with Various Strategies of Patient-Controlled Analgesia (PCA)

 10-EI-0098:

A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema

 10-DK-0002:

Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study

 10-CC-0124:

The Influence of Ritonavir, Alone and in Combination with Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

 10-CC-0006:

Evaluation of Outcome Measures for Patients Diagnosed with Traumatic Brain Injury

 10-C-0181:

Phase 1 Dose-Escalation Study of Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Recurrent B Cell Lymphoma

 10-C-0146:

Phase II Study of IMC-A12 in Patients with Mesothelioma Who Have Been Previously Treated with Chemotherapy

 10-C-0079:

A Phase 2 Study of AZD6244 in Multiple Myeloma

 10-C-0078:

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

 10-C-0028:

Phase II Study of Clinical Activity of Pegaspargase in Women with Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

 10-C-0019:

Development and Validation of a Symptom Scale for Children with Chronic Graft-Versus-Host Disease

 09-N-0160:

Convection Enhanced Delivery of Muscimol to Study the Pathophysiology Underlying the Clinical Features of Parkinson's Disease

 09-N-0124:

Effects of Reward on Learning in the Motor Cortex

 09-M-0177:

CO2 Inhalation and Risk for Panic Disorder

 09-HG-0009:

Participant Reactions to Disease Risk Information

 09-H-0245:

Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization with the H1N1 Vaccine

 09-H-0239:

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization with the H1N1 or Seasonal Influenza Vaccines

 09-H-0215:

Multi Center Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging using 320-Detector Computed Tomography

 09-H-0164:

Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients with Prior Equivocal Stress Test for Detection of Coronary Artery Disease

 09-EI-0008:

Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration

 09-DK-0238:

Diet-Induced-Obesity Resistant Phenotypes in Humans

 09-DK-0097:

Vitamin E Pharmacokinetics and Biomarkers in Women

 09-DK-0067:

Long-Term Follow-Up of HALT-C Sustained Virologic Responders

 09-DK-0058:

Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers:The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3

 09-DK-0055:

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

 09-CH-0213:

Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine

 09-CH-0185:

Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine

 09-CH-0063:

Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

 09-CC-0217:

Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteers

 09-CC-0135:

Probiotic Ingestion and Isoagglutinin Titers

 09-C-0243:

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children with Recurrent/Refractory CNS Tumors

 09-C-0214:

A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine (FdCyd + THU)

 09-C-0212:

Multicenter Phase II Study of IMC-A12 in Patients with Thymoma and Thymic Carcinoma who have been Previously Treated with Chemotherapy

 09-C-0139:

A Pilot Study of Vaccination with Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

 09-C-0138:

A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors

 09-C-0107:

Phase II Study of Neoadjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2), Non-Squamous Cell Non-Small Cell Lung Cancer

 09-C-0101:

Open Label Phase I Study to Evaluate the Safety and Tolerability of Vaccine (GI-6207) Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae Genetically Modified to Express CEA Protein in Adults with Metastatic CEA-Expressing Carcinoma

 09-C-0089:

A Targeted Ph I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade (Registered Trademark)), in Adults with Solid Tumors with a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Ca (

 09-C-0080:

A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging

 09-C-0077:

An Open-Label Clinical Trial of MORAb-009 in Combination with Pemetrexed and Cisplatin in Subjects with Mesothelioma

 09-C-0065:

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in T and NK-Cell Lymphomas

 09-C-0054:

A Group Wide Biology and Banking Study for Phase II Study of R1507

 09-C-0048:

A Phase I Study of ABT-888 in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

 09-C-0024:

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults

 09-C-0018:

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Adults with Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Two or More Prior Treatment Regimens

 09-C-0003:

A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Adults with Advanced Malignancies and Varying Degrees of Liver Dysfunction

 09-AR-0006:

A Multi-Center, Open Label, 24-Month Treatment Study to Establish the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of Canakinumab (anti-IL-1 Beta Antibody) in Patients with NOMID / CINCA Syndrome

 08-N-0134:

Pilot Study of Tolerability of Lithium Therapy in Patients with Spinocerebellar Ataxia Type I (SCA1)

 08-N-0045:

Investigation of the Dopamine System in Frontotemporal Dementia

 08-N-0012:

L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone

 08-M-0196:

An Investigation of the Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder

 08-M-0124:

Measurement of P-Glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography

 08-M-0002:

Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

 08-I-0201:

Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection

 08-I-0171:

A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP In Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection

 08-I-0093:

A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC

 08-HG-0122:

Patient-Provider Communication and Interaction in a Virtual Clinical Setting

 08-H-0177:

Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)

 08-H-0084:

Evaluation of Systemic Toxicity Associated with Allogeneic Peripheral Blood Stem Cell Infusion

 08-DK-0187:

Natural History and Pathophysiology of Gastrointestinal Graft Versus Host Disease

 08-D-0018:

Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome

 08-CC-0220:

A Phase II Clinical Trial to Determine the Effectiveness of Problem Solving Education in Caregivers and Patients during Allogeneic HSCT

 08-CC-0193:

Research Participant Perception of Care Project: Part 1: Focus Groups of Research Participants and Research Professionals to Identify Key Dimensions of the Research Participant Experience

 08-CC-0032:

Parental Permission and Adolescent Assent and Decision Making in Clinical Research

 08-C-0166:

An Open Label Pilot Study to Evaluate the Effect on the Immune System of Talactoferrin in Adults with Non-Small Cell Lung Cancer (NSCLC)

 08-C-0164:

A Phase II, Multicenter, Open-Label Trial Evaluating the Activity and Tolerability of Romidepsin (Depsipeptide, FK228) in Progressive or Relapsed Peripheral T-cell Lymphoma Following Prior Systemic Therapy

 08-C-0162:

Transfer of Autologous T Cells Transduced with the Anti-MART-1 F5 T Cell Receptor in High Risk Melanoma

 08-C-0148:

A Pilot Study of Imatinib Mesylate in Children and Adults with Sclerotic Skin Changes of Chronic Graft-Versus-Host Disease

 08-C-0128:

A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors

 08-C-0104:

Phase II Study in Patients with Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of gp100 Reactive Peripheral Blood Lymphocytes (PBL) and High or Low Dose Aldesleukin

 08-C-0101:

A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas

 08-C-0096:

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

 08-C-0086:

A Phase 2, Open-Label, Two Arm Trial to Evaluate the Efficacy of PF-00299804 in Patients with Advanced NSCLC after Failure of at Least One Prior Chemotherapy Regimen and Failure of Prior Treatment with Erlotinib

 08-C-0080:

SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas

 08-C-0074:

A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC)

 08-C-0071:

Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer

 08-C-0035:

A Pharmacodynamic Study of the P-glycoprotein (Pgp) Antagonist, CBT-1(Registered Trademark), Evaluating Pgp Inhibition in Tumors and Normal Tissues

 08-C-0033:

Multicenter Phase II Study of Belinostat (PXD-101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma

 08-AR-0218:

Phase II Trial of Rilonacept for Treatment of Familial Mediterranean Fever (FMF)

 08-AR-0008:

Insulin Resistance and Atherosclerosis in a Sample of Women with Systemic Lupus Erythematosus

 07-M-0209:

PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [F-18]FBR

 07-I-0171:

Treatment for Growth Failure in Patients with X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment with Insulin-like Growth Factor-1 (IGF-1)

 07-I-0167:

VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules with an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults

 07-H-0225:

A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with RAEB-1 AND RAEB-2 Myelodysplastic Syndrome (MDS) and AML with Trisomy 8

 07-H-0196:

Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease

 07-H-0181:

Pulmonary Hypertension and the Hypoxic Response in SCD

 07-H-0177:

Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy

 07-H-0159:

Efficacy of WT1 and PRI Peptide Vaccination for Patients with Low Risk Myeloid Malignancies

 07-H-0136:

Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies

 07-H-0104:

A Phase II Study of Lenalidomide Revlimid(Registered Trademark) in Previously Treated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

 07-EI-0213:

Laboratory of Immunology/National Eye Institute Repository

 07-EI-0025:

The Age-Related Eye Disease Study 2 (AREDS2): A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration

 07-E-0012:

Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

 07-DK-0212:

Prospective Evaluation of Albuminuria in HIV Positive Patients

 07-CH-0126:

Pilot Study of the Metabolic Effects of Betahistine Hydrochloride in Overweight Women

 07-CH-0008:

Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

 07-CC-0153:

Effects of Peripheral Blood Stem Cell Transplantation on the Microbial Flora of the Oral Cavity

 07-CC-0125:

Pilot Study of the Incidence of HLA Class I and Class II Antibodies in Platelet Donors and their Effects on the Transfusion Recipient

 07-CC-0011:

Hypnosis as a Pain and Symptom Management Strategy in Patients with Sickle Cell Disease

 07-C-0206:

A Pilot Study of Tumor Vaccination and R-hIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors

 07-C-0188:

A Double-Blind Randomized Phase 2.5 Trial of ONY-P1 Vaccine Versus Placebo in Men with D0 Prostate Cancer Following Limited Androgen Ablation

 07-C-0176:

A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Melanoma

 07-C-0175:

Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes

 07-C-0174:

Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes

 07-C-0121:

A Phase 2 Study of the C-Met RTK Inhibitor Foretinib (Formerly GSK 1363089) in Subjects with Papillary Renal-Cell Carcinoma (PRC)

 07-C-0097:

A Phase I Study of Batracylin (NSC320846) in Subjects with Solid Tumors and Lymphomas

 07-C-0085:

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults with Metastatic, Recurrent, or Progressive Cancer or HIV Infection

 07-C-0081:

A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)

 07-C-0064:

Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation with Costimulated, Tumor-Derived Lymphocytes

 07-C-0061:

Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, ZD6474 (Vandetanib) in Women with Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

 07-C-0059:

A Phase II Study of AZD2171 in Metastatic Androgen Independent Prostate Cancer

 07-C-0047:

A Phase I Trial of Nelfinavir (Viracept) in Adults with Solid Tumors

 07-C-0040:

A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors

 07-C-0006:

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Lymphoid Malignancies

 06-N-0174:

Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis

 06-N-0113:

Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients with Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)

 06-M-0246:

PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

 06-M-0002:

PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]rolipram

 06-I-0235:

A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin

 06-I-0197:

A Randomized Placebo Controlled Trial of Atorvastatin in HIV Positive Patients Not on Antiretroviral Medications with the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers

 06-I-0030:

Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test (TST)

 06-HG-0134:

Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1

 06-H-0208:

Cardiovascular Magnetic Resonance Imaging of Pediatric Healthy Volunteers

 06-H-0202:

Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension

 06-H-0165:

Evaluation of Endothelial and Hemodynamic Function in HIV Associated Pulmonary Hypertension and a Phase I/II Safety and Efficacy Trial of Sildenafil in HIV Associated Pulmonary Hypertension

 06-H-0082:

Telomere Repair Gene Mutations in Inflammatory Bowel Disease

 06-H-0054:

Evaluation of Synergy of Combining Hydroxyurea with Recombinant Human Erythropoietin Glycoform Alpha (rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

 06-H-0034:

A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients with Severe Aplastic Anemia: Horse ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab

 06-EI-0050:

Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol

 06-DK-0036:

Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity

 06-DK-0025:

The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment

 06-DC-0218:

Neural Modeling and Brain Imaging of Tinnitus

 06-D-0206:

Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of AdhAQP1, an Adenoviral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction

 06-D-0181:

A Randomized, Placebo Controlled, Proof of Concept, Study of Raptiva, a Humanized Anti-CD-11a Monoclonal Antibody, in Patients with Sjogren's Syndrome

 06-D-0144:

Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal

 06-CH-0090:

Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Shrink Leiomyomata

 06-CH-0039:

Pilot Program for Targeted Prevention of Adolescent Weight Gain

 06-CH-0038:

Body Heat Content and Dissipation in Obese and Normal Weight Adults

 06-C-0250:

A Phase II Trial of Bevacizumab and Irinotecan for Patients with Recurrent High-Grade Gliomas Immediately Following Tumor Progression after Treatment w/Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)

 06-C-0221:

A Phase I Trial of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Advanced Malignancies

 06-C-0200:

A Phase 1 Study of the Safety and Efficacy of GC1008: A Human Anti-Transforming Growth Factor-Beta (TGFBeta) Monoclonal Antibody in Patients with Advanced Renal Cell Carcinoma or Malignant Melanoma

 06-C-0198:

A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

 06-C-0152:

Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents with Refractory or Recurrent Solid Tumors

 06-C-0088:

A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver

 06-C-0083:

Phase I and Pharmacokinetic Study of BAY 43-9006 (Sorafenib) in Patients with Kaposi's Sarcoma

 06-C-0064:

A Phase II Trial of Bevacizumab for Patients with Recurrent High-Grade Gliomas

 06-C-0063:

A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas

 05-N-0245:

A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients with Friedreich's Ataxia

 05-N-0189:

Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders

 05-N-0179:

MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle

 05-N-0063:

NINDS Biomarkers in Multiple Sclerosis Study (BioMS)

 05-M-0225:

An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent

 05-I-0127:

Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients with HIV/AIDS

 05-HG-0236:

Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy

 05-HG-0076:

Long-Term Clinical Trial of Nitisinone in Alkaptonuria

 05-HG-0004:

Clinical Investigations into Hutchison-Gilford Progeria Syndrome

 05-H-0163:

Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: A Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144

 05-H-0114:

Evaluation of Systemic Nitrite Infusion and Its Effect on Exercise Physiology and Metabolism

 05-H-0019:

A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis

 05-H-0016:

Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

 05-DC-0238:

Effects of Sleep Deprivation and Recovery Sleep on Speech, Language and Other Higher Cognitive Functions: A Combined EEG-fMRI Study

 05-D-0052:

Stereo Photogrammetry Soft Tissue in Normal Individuals and Patients with Craniofacial Dysmorphologies

 05-CH-0037:

The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag

 05-CC-0216:

Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation

 05-CC-0093:

The Effect of Animal-Assisted Therapy on Distress in Oncology Patients Being Treated for Pain

 05-CC-0082:

The Influence of Concurrent Administration of Echinacea Purpurea, Ginkgo Biloba, or Panax Ginseng on the Steady State Pharmacokinetic Profile of Lopinavir/Ritonavir in Healthy Volunteers

 05-CC-0041:

Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets

 05-CC-0012:

Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation

 05-CC-0008:

Revising Employee Benefits for the Sake of Health

 05-C-0241:

A Pilot Study of Image Guided Prostate and Pelvic Nodal Irradiation with Intensity Modulated Radiation Therapy (IMRT) in Prostate Cancer

 05-C-0229:

A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination with PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults with Metastatic Breast Cancer

 05-C-0191:

A Phase I Study of Image Guided Dose Escalation with Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer

 05-C-0185:

Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

 05-C-0167:

Phase I Trial of a PSA Based Vaccine and an Anti-CTLA-4 Antibody in Adults with Metastatic Androgen Independent Prostrate Cancer

 05-C-0150:

A Study of Central Nervous System Disease in Pediatric HIV in the HAART Era

 05-C-0136:

A Phase I Trial of Enzastaurin (LY317615) in Patients with Recurrent Gliomas

 05-C-0134:

A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma

 05-C-0031:

A Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype with Local GM-CSF in First Complete Remission

 05-C-0022:

A Phase I Trial of BAY 43-9006 (Sorafenib) and Bevacizumab in Refractory Solid Tumors with Biologic and Proteomic Analysis

 05-AR-0014:

Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis

 04-NR-0069:

Evaluation of Efficacy and Mechanisms of Topical Thalidomide for Chronic Graft-Versus-Host-Disease Related Stomatitis

 04-M-0270:

Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion

 04-M-0183:

Association between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects with Panic Disorder and Healthy Controls

 04-H-0213:

Cytokine Gene Polymorphisms in Bone Marrow Failure

 04-H-0198:

A Pilot Trial of an Accelerated Immunization Schedule with ALVAC-pp65 (vCP260) for Inducing CMV-Specific Immunity in Stem Cell Allotransplant Donors and Healthy Volunteers

 04-H-0112:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism

 04-DK-0193:

Identification and Mechanistic Investigations of Tolerant Kidney Transplant Recipients

 04-DK-0099:

Depletional Induction with Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients

 04-DK-0061:

A Comparison of Free Fatty Acid Flux in African Americans and Caucasians

 04-DK-0057:

Renal Transplantation in Recipients with Nephropathic Cystinosis

 04-CH-0050:

Eating Behavior in Children

 04-CC-0184:

Influence of MDR-1 CYP3A4 and CYP3A5 Genotypes/Haplotypes on Sirolimus Pharmacokinetics and Pharmacodynamics in Patients with Renal Transplantation

 04-CC-0178:

The Treatment of Deep Vein Thrombosis of the Lower Extremities with "Low-Dose" Alteplase: a Pilot Study

 04-CC-0070:

Exploring Patient-Provider Trust among Individuals with End-Stage Renal Disease

 04-CC-0046:

Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors

 04-CC-0032:

Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease

 04-C-0273:

A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver

 04-C-0257:

A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients with Androgen-Independent Prostate Cancer

 04-C-0246:

An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination with Sargramostim in Adults with Metastatic Carcinoma

 04-C-0238:

A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors

 04-C-0232:

A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse

 04-C-0173:

Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas

 04-C-0171:

A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization with the APT-MRI System

 04-C-0142:

A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas

 04-C-0131:

Allogeneic Breast Protocol 2: Phase I Trial of T Cell Exchange with Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for Metastatic Breast Cancer

 04-C-0095:

A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe Systemic Lupus Erythematosus

 04-C-0089:

Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia

 04-C-0080:

Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

 04-C-0049:

A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients with Refractory or Recurrent Non-Small Cell Lung Cancer

 04-C-0044:

A Trial of Exemestane in Postmenopausal Women with DCIS or at High Risk for Invasive Breast Cancer

 04-C-0031:

Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease

 03-N-0293:

Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke

 03-N-0203:

SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro

 03-M-0014:

Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging

 03-H-0282:

Characterization of Cardiac Function in Subjects with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I

 03-H-0249:

A Randomized Trial of Immunosupression in Aplastic Anemia Patients with Refractory Pancytopenia or Suboptimal Hematologic Response after h-ATG/CsA Treatment

 03-H-0201:

Cytokine Gene Polymorphisms in Allotransplant Donors

 03-H-0193:

A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects with Severe Aplastic Anemia

 03-H-0192:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism

 03-H-0051:

Collection of Blood, Stool, Bone Marrow and/or Tissue Samples from Subjects with Hepatitis-Associated Aplastic Anemia

 03-DK-0245:

Effect of AC 2993 (Synthetic Exendin-4) - Administered Alone or in Combination with Daclizumab - on Islet Function in Patients with Type I Diabetes

 03-DK-0226:

Pulse Dexamethasone Over 48 Weeks for Podocyte Disease

 03-DK-0132:

The Pathogenesis of Chronic Graft Failure after Kidney Transplantation

 03-DK-0071:

Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy

 03-CH-0225:

Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome

 03-CC-0301:

Health Beliefs and Health Behavior Practices among Minorities with Rheumatic Diseases

 03-CC-0127:

Evaluation of Potential Synergy of Combining Hydroxyurea with Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

 03-C-0304:

Pilot Trial of Alemtuzumab and Dose-Adjusted Epoch in Chemotherapy Naive Aggressive T and NK-Cell Lymphomas

 03-C-0194:

Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia

 03-C-0190:

Trans-Rectal Placement of Prostatic Fiducial Markers under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study

 03-C-0124:

Follow-Up Study of Breast Cancer and Multiple Myeloma Subjects Previously Enrolled in Retroviral Gene Transfer Studies

 03-C-0110:

Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma

 03-C-0077:

A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, with Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies

 03-C-0030:

Phase I Trial of Romidepsin Given on Days One, Three, and Five in Patients with Thyroid and Other Advanced Cancers

 03-C-0002:

A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas

 03-AR-0130:

Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study

 02-M-0092:

Reward-Related Processes and Brain Function

 02-M-0047:

Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders

 02-M-0036:

A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control

 02-M-0007:

Adolescent Medial Temporal Lobe Function in Health and Illness

 02-H-0265:

Identification of Genes Expressed in Atherosclerotic Plaques

 02-H-0111:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Role of Preparative Regimen and T Cell Dose in Graft Rejection and GVHD

 02-CH-0309:

The Diagnostic Performance of Screening Tests for the Diagnosis of Cushing's Syndrome

 02-CH-0287:

Treatment of Leiomyomata with the Selective Progesterone Receptor Modulator CDB-2914

 02-CH-0278:

Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants

 02-CH-0100:

Supplemental Calcium in Overweight Out-Patients

 02-CC-0044:

Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the National Naval Medical Center (NNMC) Breast Care

 02-C-0268:

Prospective Study of Prophylactic Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer

 02-C-0259:

Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas

 02-C-0215:

Amifostine as a Rectal Protector during External Beam Radiotherapy for Prostate Cancer: A Phase II Study

 02-C-0207:

A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer

 02-C-0205:

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion with or without Concurrent Celecoxib in Subjects with Pulmonary and Pleural Malignancies

 02-C-0193:

A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) in Children with Diffuse Pontine Gliomas

 02-C-0130:

A Phase II Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Renal Cell Carcinoma

 02-AR-0272:

A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus

 02-AR-0156:

A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab in Patients with Dermatomyositis and Polymyositis

 01-M-0152:

Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study

 01-H-0223:

Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension

 01-H-0162:

Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for Hema

 01-H-0031:

National Heart, Lung, and Blood Institute Data Repository

 01-DK-0249:

Ingested Interferon-Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus

 01-DK-0247:

Treatment of Chronic Delta Hepatitis with Pegylated Interferon

 01-DK-0246:

Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B

 01-DK-0036:

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

 01-CH-0086:

A Combination Therapy with Cystagon and N-Acetylcysteine for INCL Patients

 01-C-0235:

Combination Antibody Therapy with Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL

 01-C-0222:

A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

 01-C-0144:

Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study

 01-C-0125:

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

 01-C-0104:

A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

 01-C-0091:

Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors

 01-C-0049:

Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

 01-C-0027:

Natural History of Plexiform in Neurofibromatosis Type I

 01-C-0009:

Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study

 01-C-0008:

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study

 00-N-0140:

A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas

 00-N-0057:

Positron Emission Tomography Imaging of Activation-Induced Signal Transduction in Human Brain

 00-I-0143:

Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)

 00-H-0169:

A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

 00-H-0032:

Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)

 00-H-0029:

A Pilot Study of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

 00-DK-0196:

Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction with Thymoglobulin

 00-DK-0186:

The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therap

 00-DK-0042:

Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study

 00-CH-0136:

A Trial of Pamidronate in Children with Osteogenesis Imperfecta

 00-CH-0134:

Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children with Insulin Resistance

 00-C-0201:

Active Immunization of Sibling Stem Cell Transplant Donors Against Purified Myeloma Protein of the Stem Cell Recipient with Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation

 00-C-0193:

A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals

 00-C-0133:

Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma

 00-C-0121:

A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors

 00-C-0092:

A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy

 00-C-0080:

A Double Blinded Randomized Crossover Phase III Study of Oral Thalidomide versus Placebo in Patients with Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation

 00-C-0030:

A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapax(Trademark)) in the Therapy of Tac-Expressing Adult T-Cell Leukemia

 00-C-0018:

A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated with Relapse

 99-I-0015:

Immunologic and Virologic Characterization of HIV-Infected Patients After Cessation of Highly Active Antiretroviral Therapy (HAART)

 99-HG-0056:

Pulmonary Fibrosis Associated with Rheumatoid Arthritis: Definition of the Natural History of Disease

 99-H-0064:

Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy

 99-H-0046:

Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine

 99-DK-0120:

Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant

 99-DK-0119:

Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

 99-DK-0107:

Live Donor Renal Donation for Allotransplantation

 99-D-0070:

Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome

 99-C-0143:

Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation

 99-C-0137:

Vaccine Therapy with Tumor Specific p53 Peptides in Adult Patients with Low Burden Adenocarcinoma of the Ovary

 99-C-0088:

(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy

 99-C-0081:

Methods in Education for Breast Cancer Genetics

 99-C-0053:

Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study

 98-HG-0124:

Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium

 98-CH-0111:

Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents with Obesity-Related Comorbid Conditions

 98-C-0139:

Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma

 97-M-0126:

Childhood Onset Psychotic Disorders: Characterization and Treatment with Atypical Neuroleptics

 97-HG-0085:

Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

 97-H-0202:

Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults

 97-H-0196:

A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy

 97-H-0130:

Collection of Blood and Bone Marrow from Healthy Volunteers and Patients for Research Purposes

 97-H-0117:

A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia

 97-H-0099:

HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies

 97-DC-0180:

Genetic Analysis of Human Hereditary Hearing Impairment

 97-C-0178:

Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

 97-C-0093:

A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors

 97-C-0052:

A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors after Cytoreductive Therapy in Metastatic Pediatric Sarcomas

 97-C-0050:

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

 97-C-0040:

EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma

 96-M-0124:

Genetics of Obsessive-Compulsive Disorder: A Collaborative Study

 96-CH-0101:

Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents

 96-CH-0033:

An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia

 96-C-0104:

A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer

 95-HG-0165:

Outcomes of Education and Counseling for HNPCC / Lynch Syndrome Testing

 95-HG-0158:

Genetic Analysis of Hereditary Prostate Cancer

 95-H-0167:

Effect of Hypoxia and Smoking on Oxidation of Proteins and Nucleic Acids in Human Volunteers

 95-CH-0104:

Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome

 95-C-0055:

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer

 92-CC-0141:

The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

 91-M-0230:

Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects

 91-M-0124:

Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 1.5 Tesla MRI

 90-DK-0137:

Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

 90-CH-0149:

Early Copper Histidine Therapy in Menkes Disease

 88-I-0172:

A Phase III Study with Long-Term Follow-Up of Zidovudine Versus Zidovudine and Alpha-Interferon Versus Alpha-Interferon in Patients with Early HIV Infection

 88-CH-0032:

Specificity of Mother-Infant Interaction: The Influence of Maternal Age, Employment Status, and Parenthood Status

 86-H-0088:

Lymphocytapheresis of Patients with Pancytopenia

 85-M-0115:

Biological Markers in Childhood Psychiatric Disorders

 85-H-0105:

Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia

 85-H-0087:

Clinical Course of Patients with Transfusional Hemochromatosis on Deferoxamine

 84-H-0029:

Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

 84-CH-0169:

Endocrine Studies of Healthy Children

 81-N-0010:

Regional Cerebral Utilization of Glucose in Patients with a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders

 79-C-0111:

The Treatment of Stage I and II Carcinoma of the Breast with Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 05/16/2012